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Abstract 
 
Humans and wildlife are constantly exposed to ubiquitous environmental 
chemicals which have the capability to disrupt the endocrine system. These 
endocrine disrupting compounds (EDCs) are found within everyday items 
including food cartons, baby-milk formula and can even be inhaled in dust 
particles. In utero exposure to EDCs has been found to disturb normal fetal 
hypothalamic, pituitary, gonadal and thyroid function in both genders. In 
contrast, despite increasing evidence of correlation between EDCs and 
metabolic diseases, chemical effects on the adrenal gland have received little 
attention. This study examined ovine fetal adrenal glands available from 
pregnant domestic sheep (Ovis aries) exposed to a real-life cocktail of EDCs 
found within human sewage sludge fertiliser (normal agricultural practice). 
Ewes were exposed for 80 day windows (0-80, 30-110, 60-140), or continually 
throughout gestation (0-140 days) and fetal adrenals subjected to 
immunohistochemistry for specific markers (CYP17A1 and AGTR1) or to real 
time PCR for the target genes (CYP11A1, CYP17A1, 3βHSD, MC2R, AGTR1 and 
ER1). Adrenal zone thickness stained for AGTR1 and CYP17A1 protein were 
significantly reduced (p=0.037 and p=0.031 respectively). AGTR1 and CYP17A1 
gene expression exhibited  a significant treatment by gender interaction 
(p=0.027 and p=0.032 respectively) in the females from the mid and late 
gestation treatment groups.  ER1 gene expression was also significantly 
reduced  in mid and late treatment goups compared with controls (p=0.042). 
These data illustrate that in utero exposure to EDCs within sewage sludge 
dysregulates the developing ovine fetal adrenal gland. It is hypothesised that 
this fetal adrenal dysregulation may contribute to the increasing incidence of 
human metabolic disease.   
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1. Introduction 
 
Since the publication of Rachel Carson’s “Silent Spring” in 1962 (Carson, 
1962), there was a period of increased awareness and concern over 
environmental contaminants. These pollutants have the profound capability 
to harm human and wildlife populations. These chemicals are associated with 
increased incidences of specific adult diseases as well as perturbed 
reproductive function, and reduced biodiversity. Even Joni Mitchell sang “Hey 
farmer, farmer put away that DDT now, give me spots on my apples, but leave 
me the birds and the bees, please!” referring to the organochloride pesticide 
dichlorodiphenyltrichloroethane (DDT), which is now banned in the USA and 
Europe, but still widely used globally to combat malaria-spreading mosquitos. 
However, in popular culture, references to environmental pollutants have 
been put aside, and from personal experiences, the general population is very 
naïve to the possible consequences.  
Many of these environmental chemicals induce their effects by adversely 
interacting with the endocrine system, particularly during pregnancy. This 
problem posed by such contaminants, collectively termed the Endocrine 
Disrupting Compounds, or EDCs, due to their capabilities to disrupt the 
endocrine system, is highlighted by two disturbing observations: 
1. Increasing endocrine related disease in humans, for example, reduced 
fertility and increased metabolic diseases, including obesity; 
2. Decreasing biodiversity and increasing abnormalities observed within 
aquatic and terrestrial ecosystems. 
Worryingly, the USA EDC screening program estimated there to be 
approximately 10,000 ubiquitous chemicals with the potential to interfere 
with the endocrine system (EPA, 2014). 
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Normal physiology is controlled by an abundance of response-producing 
molecules, or hormones, derived from cholesterol, which are secreted 
throughout the body into the venous circulation by glandular organs: the 
Endocrine System. Briefly, the hypothalamus of the brain produces many 
stimulating and inhibiting hormones, which bind with specific receptors to 
cause a cascade of events resulting in a response. Hypothalamic hormones 
bind to receptors within the pituitary gland, to cause the release of further 
hormones, which then specifically act upon their target organs, for example, 
the adrenal gland to produce cortisol, or the gonads to produce sex 
hormones. These end step target gland hormones negatively feedback to the 
hypothalamus and pituitary gland to regulate the production of the initiating 
hormones. A summary of the endocrine system can be seen in Figure 1. The 
endocrine system enables homeostasis to be maintained; therefore any 
compound with the capabilities of disrupting this finely balanced system, has 
the potential to cause widespread physiological harm by dysregulating 
homeostatic mechanisms.  
 
Figure 1: Summary of the main organs involved within the Endocrine System. 
 
1.1: Endocrine Disrupting Compounds  
 
In 2001, McLachlan defined EDCs as chemicals with the ability to mimic or 
block vertebrate steroid hormones due to interaction at the receptor site 
(McLachlan, 2001). The following year, the International Program on Chemical 
Safety (IPCS) produced the following definition (IPCS, 2012): 
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 “An endocrine disruptor is an exogenous substance or mixture that alters 
function(s) of the endocrine system and consequently causes adverse health 
effects in an intact organism, or its progeny, or (sub)populations. 
A potential endocrine disruptor is an exogenous substance or mixture that 
possesses properties that might be expected to lead to endocrine disruption in 
an intact organism, or its progeny, or (sub)populations.”  
Anthropogenic pollutants consisting of numerous heavy metals and synthetic 
organic compounds are ubiquitous and persistent in the environment due to 
their widespread use in agricultural practice as pesticides and fertilisers, as 
pharmaceuticals and as constituents of everyday items. It is well documented 
that low environmental levels of these chemicals can disrupt the endocrine 
systems in a wide range of animal species. Studies have shown there are 
hundreds of environmental chemicals with oestrogenic properties (Nishihara 
et al., 2000). The developing fetus is therefore the most susceptible to harm, 
and EDCs have the ability to alter the structure and function of organs in 
future generations who were not directly exposed (Steinberg et al., 2008). 
Global chemical production has now increased to become worth over €3,127 
billion annually (The European Chemical Industry Council, 2013) which relates 
to 400 million tons (Casals-Casas et al., 2008) and the US Environmental 
Protection Agency “is considering 87,000 substances as potential candidates 
for testing” as EDCs (EPA, 2014).  
Humans and animals are exposed to chronic low concentrations, or doses, of 
these EDCs in their everyday environment; low dose exposure is defined as “a 
dose below the lowest dose at which a biological change (or damage) for a 
specific chemical has been measured in the past, i.e. any dose below the 
lowest observed effect level or lowest observed adverse effect level (LOAEL)” 
(Welshons et al., 2006). However, at environmentally relevant low levels, 
EDCs are still able to cause adverse physiological effect, especially when 
present in mixtures as found in the environment. Notably, this complex 
mixture can be antagonistic, synergistic or additive in effect (Rhind et al., 
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2010a, Kortenkamp, 2007).  Furthermore, EDCs do not follow normal 
toxicological rules: an increased dose does not necessarily result in an 
increased effect. Instead EDCs have the capacity to follow the rules of non-
monotonicity: this means the dose response increases and decreases with 
increasing dose (Vandenberg et al., 2012). 
 
1.1i: Routes of Chemical Exposure  
 
Routes of human exposure to EDCs include consumption of meat and dairy 
products, ingestion of water, inhalation and absorption through the skin 
(Fowler et al., 2008). The main means of exposure for animals and humans is 
oral consumption, either through food or contaminated water sources, the 
latter becoming increasingly problematic (Stuart et al., 2012). However, there 
is also increasing evidence of inhalation of volatile chemicals, which are on 
the rise in industrial centres, and can be absorbed through the skin (Rhind et 
al., 2010a). One major oral source of contamination for livestock is through 
pesticides, herbicides and fertilisers that are regularly used to treat pastures. 
Traditional organic manure and sewage fertiliser had been replaced with 
inorganic man-made nitrate fertilisers. However, the economic and 
environmental cost of using and producing these synthetic fertilisers has 
resulted in a resurgence in sewage sludge usage (Swanson et al., 2004). 
Sewage sludge fertiliser, or biosolids, is a bi-product of human wastewater 
treatment, and is often available free of charge from the large wastewater 
management centres. It contains high concentrations of nitrogen and 
phosphorus required for grass production; however, it contains relatively high 
concentrations of EDCs (Rhind et al., 2005b, Stevens et al., 2003).  
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1.2: The Importance of EDCs 
 
It is estimated that 24% of all human disease can be attributed, at least in 
part, to environmental factors (Pruss-Ustun and Corvalan, 2007). Fifteen to 
20% of human couples have difficultly conceiving, and there are clear links 
between environmental contaminants and human infertility (Hruska et al., 
2000). Studies have shown EDCs have negative effects on fetal gonads as well 
as affecting the hypothalamic pituitary gonadal (HPG) axis (Paul et al., 2005, 
Fowler et al., 2008, Bellingham et al., 2013), thyroid (Hombach-Klonisch et al., 
2013), adrenal and the hypothalamic pituitary adrenal (HPA) axis (Hinson and 
Raven, 2006, Kaludjerovic and Ward, 2012). In addition, there is an increased 
incidence of metabolic diseases, including obesity and type 2 diabetes, which 
correlates with changes in the industrial and agricultural chemical procedures 
initiated over the past 40 years (Casals-Casas et al., 2008).   
It is not only humans that suffer the consequences of EDC exposure. Global 
biodiversity is declining at a terrifying rate for numerous reasons: poaching, 
deforestation and global warming to name but a few. EDCs are also 
contributing to this diminishing pool of wildlife. For example, Lake Apopka in 
North America is famous not only for alligators (Alligator mississippiensis), but 
also for high EDC burdens including the now banned DDT. The alligators in 
this lake, and others containing high ions of organochloride pesticides, have 
low egg clutch viability compared to controls, leading to lower population 
numbers of juvenile alligators (Rauschenberger et al., 2007). EDC 
contaminated lakes alter plasma hormone concentrations, steroiodenesis and 
gonadal morphology (Guillette et al., 2000). Avian species are also in decline, 
and DDT has been shown to reduce egg hatchability due to eggshell thinning 
(Bernanke and Kohler, 2009). 
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1.2i: Cancer 
 
A number of lines of evidence suggest that exposure to EDCs may be related 
to an increase in the incidence of various cancers, particularly those 
associated with the reproductive system. Epidemiological studies have 
demonstrated an increased risk of prostate cancer, for example in agricultural 
workers in the United States. A prospective study of over 55,000 individuals 
from the American Agricultural Health Study Cohort demonstrated that 
prostate cancer appears to be associated particularly with the use of 
organochlorine pesticides, including DDT and dieldrin in Caucasians (Meyer et 
al., 2007).   
Studies of animal models of breast cancer have identified at least 216 
chemicals, including many EDCs, which are associated with an increase in 
mammary gland tumours (Rudel et al., 2007). Human epidemiological studies 
have linked various EDCs with breast cancer, including the organochlorine 1,1-
dichloro-2,2-bis(p-chlorophenyl) ethylene (DDE), levels of which were found 
to be significantly higher in women with breast cancer than those without 
(Wolff et al., 1993). However, not all studies have managed to fully 
substantiate a link. Knower and colleagues reviewed a number of known 
EDCs, and even though epigenetic effects seem apparent, the link between 
EDCs and, in this case, mammary cancers, are incredibly varied and complex, 
and further investigations are required (Knower et al., 2014). One potential 
mechanism is the modification by EDCs of known risk factors for the 
development of breast cancer. For example, certain EDCs have been shown to 
reduce the age of menarche; early menarche is an accepted risk factor for 
breast cancer.  
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1.3: Environmental EDCs  
 
Environmental chemicals with the capacity to induce hormonal effects include 
solvents, pesticides, heavy metals, bi-products of the pharmaceutical 
industry, cosmetics and plasticisers to name a few. Different families of 
chemicals have different hormonal properties. Some environmental 
xenobiotics have the capacity to disrupt the endocrine system in their original 
form, however, others have to be converted and transformed within the body 
before they become hormonally active (IPCS, 2012). 
 
1.3i: Persistent Organic Pollutants  
 
Persistent organic pollutants (POPs) are chemicals found within the 
environment with the capacity to persist for long periods of time without 
degrading, and with the potential to bio-accumulate in animals. POPs can be 
detected in fat stores of animals and are generally found at higher 
concentrations in those species at the top of the food chain (IPCS, 2012). One 
example of a POP is the polychlorinated biphenyl group of chemicals.  
 
Polychlorinated biphenyls 
 
Polychlorinated biphenyls (PCBs) are lipophilic, synthetic chemicals with two-
linked benzene rings and a combination of hydrogen and chloride atoms, 
which were used until the 1980s for insulating and sealing buildings 
(Annamalai and Namasivayam, 2015). PCBs have both oestrogenic and anti-
oestrogenic activity at the level of the oestrogen receptor (Connor et al., 
1997), and a number of PCB congeners have the capacity to bio-accumulate 
(Annamalai and Namasivayam, 2015). Even though PCBs were banned 
decades ago due to their high environmental persistence, waste disposal and 
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incineration has resulted in continuing contamination today (Steinberg et al., 
2008). PCBs have a history of concern due to their capacity to alter 
reproductive function (Cillo et al., 2007) as well as having carcinogenic 
properties (National Toxicology Program, 2010).  
Due to their lipophilic nature and the increasing fat mass in people, 
interactions between PCBs and disease is likely to be on the increase in 
modern day populations (Kim et al., 2015). POPs including PCBs, have been 
correlated with altered thyroid function, lower birth weights, altered neural 
development and reproductive disturbances (Annamalai and Namasivayam, 
2015). An environmentally relevant mixture of PCBs (Aroclor-1254) has been 
found to severely disrupt rat prostate cell morphology and cause DNA 
damage (Cillo et al., 2007).  PCBs have also been associated with 
hypertension, however, this was only shown in cohorts of the population with 
an above average body mass index due to increased potential PCB storage in 
adipose tissue (Arrebola et al., 2015). 
 
1.3ii: Phthalates  
 
Phthalates are esters of phthalic acid and are added as plasticisers to plastics 
used in windows, toys and even food containers. Unlike PCBs, phthalates are 
not persistent in the environment, and act as anti-androgens resulting in 
perturbations of male genitalia (Annamalai and Namasivayam, 2015). Indirect 
maternal exposure to monobutyl phthalate (MBuP) during late pregnancy in 
rats increased rates of cryptorchidism, lowered birth weights, decreased 
anogential distance in male offspring and caused an overall increase in 
pregnancy loss (Ema and Miyawaki, 2001). However, it is important to 
distinguish this as a toxicological study, as high concentrations of phthalates 
were used rather than environmentally relevant concentrations. Other male 
reproductive perturbations caused by anti-androgen phthalates include 
reduced sperm quality, suppression of fetal androgen levels and internal and 
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external genital malformations (Schug et al., 2011). However, it is not only 
males that are affected by phthalates. A statistically significant association 
between elevated female periconception urine concentrations of 
monoethylhexyl phthalate and pregnancy loss has been found in a cohort of 
430 Danish couples (Toft et al., 2012). In utero exposure to PCBs causes most 
harm. Maternal exposure to phthalates have been associated with early 
thelarche, endometriosis, reduced semen quality and reduced anogenital 
distance in offspring (Diamanti-Kandarakis et al., 2009). In utero exposure to 
the phthalate di-(2 ethylhexyl) phthalate (DEHP) (which has been found in 
amniotic fluid) induced epigenetic changes and hotspots of dysregulated gene 
expression in the offspring, primarily targeting the immune system (Martinez-
Arguelles and Papadopoulos, 2014). Worryingly, not only are metabolites of 
DEHP found in consumer cow milk, but also human milk and baby formula 
(Mortensen et al., 2005).  
 
1.3iii: Brominated Flame Retardants  
 
Halogen-containing flame-retardants are used widely for preventing fires in 
electrical equipment and, particularly, in soft furnishings, carpets and 
furniture. Wide reaching effects of flame retardants have been investigated, 
and include lung inflammation, ovarian malformations, hepatomegaly and 
disruption of thyroid hormones (Annamalai and Namasivayam, 2015).  
 
Bisphenol A 
 
The widespread domestic use of flame-retardants including bisphenol A 
(BPA), has resulted in constant human exposure from everyday household 
items including food tins and even within contaminated dust (Brandsma et al., 
2013). BPA has been found in human urine (Christiansen et al., 2014). 
Similarly to phthalates, in utero exposure is more harmful than adult exposure 
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and BPA causes widespread reproductive dysfunction due to its oestrogenic 
properties (Schug et al., 2011). Pregnant rats exposed to environmentally 
relevant concentrations of BPA gave birth to male offspring with reduced 
spermatogenesis and fertility and female offspring with early onset puberty 
and decreased luteinising hormone (LH) concentrations in adult life (Salian et 
al., 2011). In another rat study where pregnant dams were exposed to varying 
concentrations of BPA by gavage (0, 0.025, 0.250, 5 or 50 mg/kg body weight 
per day), anogential distance was significantly reduced in male and female 
offspring compared to controls. No other significant change in reproductive 
function was reported, for example there was no difference in reproductive 
organ weights seen in offspring by day 16 when they were euthanised. 
However, reproductive dysfunction is more likely to be evident at puberty and 
into adulthood, which was not investigated in this study (Christiansen et al., 
2014).  
 
1.4: EDC Mechanism of Action 
 
EDCs can interact in many ways at numerous sites in hormonal pathways and 
have the capability to perturb function or the metabolism of hormones by 
mimicking natural hormones with respect to transport, mode of action and 
storage (Schug et al., 2011). EDCs can act on nuclear and non-nuclear steroid 
hormone receptors, the aryl hydrocarbon receptor, and on receptors for a 
variety of other physiological mediators. EDCs are capable of wider 
physiological interference than just endocrine disruption, including on 
neurotransmitters as well as directly affecting enzymatic pathways of steroid 
biosynthesis and/or metabolism (Diamanti-Kandarakis et al., 2009).   
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1.4i: Oestrogen Receptors 
 
Numerous chemicals with oestrogenic properties and the ability to mimic 
hormones have been found in the environment (Nishihara et al., 2000). Due 
to the promiscuity of the ligand binding region of oestrogen receptors (ERs) 
(Hamlin and Guillette, 2011, Swedenborg et al., 2010), EDCs can act as 
oestrogens, binding with receptors (agonists), or by blocking the receptor 
(antagonists) (Swedenborg et al., 2010).  EDCs can also partially bind to the 
receptor, resulting in a variable response (Hamlin and Guillette, 2011), and 
many EDCs also have the ability to interact with numerous hormonal 
pathways simultaneously (Swedenborg et al., 2010).  
There are two oestrogen receptors: ER1 and ER2, which have distinct 
physiological roles (Gustafsson, 2003). Oestrogen receptors are located 
throughout the body and therefore interference by EDCs can have 
widespread consequences. Oestrogens are steroid hormones produced, like 
all steroid hormones, by a pathway of enzyme reactions from cholesterol. 
Activation of ER1 and ER2 can be by natural oestrogens including plant 
phytoestrogens, or chemicals which were never designed to modulate 
oestrogen receptors, for example DDT (Schug et al., 2011).  
The use of molecular dynamic simulations to investigate structure-activity 
relationships between oestrogen ER1 and a number of EDC xenoestrogens 
suggest that van der Waals interactions are the principle driving force in their 
binding to the oestrogen receptor by hydrogen bonding (Li et al., 2012, 
Zhuang et al., 2012). Given the apparent similarity of receptor interactions 
between endogenous oestradiol-17β and xenoestrogens, as well as the high 
biological potency of many identified EDCs, it is surprising that there are often 
only limited structural similarities between an EDC and the endogenous 
hormone, the activity of which it is mimicking (Acerini and Hughes, 2006). For 
example Figure 2 compares the structures of a number of oestrogenic EDCs 
with the naturally occurring endogenous 17β-oestradiol, and it can be seen 
that there is very limited molecular commonality.  
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Figure 2:  Examples of the chemical structures of certain EDCs with known 
oestrogenic effects (xenoestrogens), compared with the endogenous hormone 
17β-oestradiol (Acerini and Hughes, 2006). 
 
However, not all xenoestrogens are true oestrogen mimics. Some have 
oestrogenic properties by causing different signal transductions than true 
oestrogen, and have differing oestrogenic potencies (Watson et al., 2007). In 
addition, certain oestrogenic EDCs, for example BPA as discussed above, not 
only have the ability to bind to oestrogen receptors, therefore being an 
oestrogen agonist, but also binds to thyroid receptors, acting as an antagonist 
(Schug et al., 2011). 
 
1.4ii: Aryl Hydrocarbon Receptor  
 
EDCs also interact through the aryl hydrocarbon receptor (AhR), which is a 
key receptor in xenobiotic defences (Swedenborg et al., 2010). The AhR is 
ubiquitously distributed in mammalian tissues. Activation of cytosolic AhR by 
EDCs, including xenoestrogens such as PCBs, results in its translocation to the 
nucleus. Following interaction with specific dioxin-responsive DNA sequences, 
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the transcription of cytochrome P450 steroidogenic enzymes (CYPs) is 
modulated (Xiao et al., 2014), thereby potentially influencing levels of both 
sex steroids, mineralocorticoids and glucocorticoids which heavily rely on CYP 
enzymes.  
 
1.4iii: Epigenetics  
 
One mechanism whereby EDCs may affect the fetus is via modification of 
epigenetic mechanisms (Skinner et al., 2011). “An epigenetic trait is a stably 
heritable phenotype resulting from changes in a chromosome without 
alterations in the DNA sequence” (Berger et al., 2009). This is an adaptive 
response to enable changes in organogenesis to optimise survival in a 
changing environment (Crain et al., 2008, Skinner et al., 2011).  Gene 
expression can be influenced by a variety of histone and DNA modifications, 
in particular DNA methylation. In order for gene transcription to take place, 
the DNA has to be loosely coiled to enable access for the transcriptional 
machinery including RNA polymerases. Methylation results in tightly coiled 
DNA, resulting in an inactive gene, and therefore increased methylation 
results in a reduction in gene expression (Bird, 2002). The cells in different 
tissues have unique patterns of gene expression, and this is a result of 
epigenetic modifications (Bird, 2002). During development, the pattern of 
epigenetic modifications may change, a process called epigenetic re-
programing, affecting both germ cells (cells that produce the gametes) and 
somatic cells (all other cells) (Morgan et al., 2005). This presents a window of 
vulnerability to environmental signals that may lead to epigenetic 
modifications influencing the health of the offspring as well as resulting in the 
potential for trans-generational transmission. Alterations by EDCs to somatic 
cells will cause the adult onset of disease; however, alterations by EDCs to 
germ cells will result in altered transgenerational phenotypes (Skinner et al., 
2011). 
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1.4iv: Fetal Origin of Adult Disease, Transgeneration Consequences  and 
Windows of Susceptibility  
 
There is increasing evidence suggesting in utero environmental changes can 
result in variations in fetal programming, leading to altered gene expression 
and the onset of adult chronic disease (Gluckman and Hanson, 2004). 
Changes to the epigenome of offspring can be caused by maternal hormone 
and nutrient exposure in utero, and this alteration can result in altered gene 
expression and subsequent altered physiology in later life (Franklin et al., 
2010). The majority of EDCs do not alter DNA sequences, and it is thought 
developmental effects caused by EDCs encompasses changes to the 
epigenome (Skinner et al., 2011), for example by the phthalate DEHP 
(Martinez-Arguelles and Papadopoulos, 2014). In a rat model, in utero 
exposure to the PCB mixture Aroclor-1221 not only caused abnormalities in 
gender skew and LH concentrations in the daughters (F1), but even greater 
perturbations in the next generation, the grand-daughters (F2), which showed 
supressed LH and progesterone concentrations, and reduced ovarian and 
uterine weights (Steinberg et al., 2008). The authors hypothesised this 
generational effect to be either direct genotoxicity, altered methylation 
pattern, or altered hormonal concentration during development. More 
worrying still, EDCs have the potential to alter not only F1 and F2 generations, 
but also F3 generations. For example, in rodent models of diethyhexyl 
phathalate and dioxin exposure during pregnancy, F3 generations were 
affected both in males (lower sperm counts, lower germ cell function, 
abnormal seminiferous tubules) and females (reduced fertility) (Rissman and 
Adli, 2014).   
Fetuses are most sensitive to the actions of EDCs due to their undeveloped 
defences, especially to chemicals with steroidogenic activity. As many EDCs 
are lipophilic in nature, they accumulate within the developing fetus 
(Gluckman and Hanson, 2004, Hamlin and Guillette, 2011). Further sensitive 
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windows of exposure are during other critical developmental times including 
childhood and puberty (Fudvoye et al., 2014). In addition, recent studies 
suggest a transient period of exposure during fetal development is more 
detrimental than exposure throughout the entire gestation, for example, on 
ovine ovarian health (Bellingham et al., 2013). 
 
1.5: EDCs and Female Reproductive Dysfunction  
 
Female reproductive health has decreased over the past half a century, 
however, it is far more difficult to assess than male fertility as the gametes 
are inaccessible (Crain et al., 2008). EDCs are hypothesised to interfere with 
the timing of puberty in the human including earlier breast development in 
females, altered hormone concentrations including LH and progesterone, and 
reduced ovarian and uterine weight (Steinberg et al., 2008, Mouritsen et al., 
2010). In one study, Buttke and colleagues demonstrated a significant inverse 
correlation between urinary levels of certain phenolic EDCs (including 2, 5-
dichlorophenol and 2, 4-dichlorophenol) as an index of environmental 
exposure, and the age of menarche in adolescent girls, the average of which 
has now decreased to less than 13 years of age (Buttke et al., 2012). In 
addition, there has been a decrease in the proteins that are associated with 
endometriosis (MMP-9, ELNE and FAM49B), and ELNE and FAM49B levels are 
inversely correlated with the concentration of EDCs including PBDE #183, γ-
HCT and PCBs (Williams et al., 2015).  
A decreasing age of menopause has also been linked to EDC exposure.  
Eskenazi and colleagues concluded that 2, 3, 7, 8-Tetrachlorobenzo-p-dioxin 
(TCDD) was associated with an increased risk of early menopause (Eskenazi et 
al., 2005). In addition to this investigation, a cross-sectional study completed 
on 219 Hispanic women within the Health and Nutrition Examination Survey 
concluded that exposure to, and serum levels of, organochlorine pesticides 
was associated with a younger age of menopause, and this was concentration 
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dependent. Woman in the highest exposure categories (determined by serum 
concentrations of pesticide) reached menopause up to 5.7 years earlier than 
women with undetectable levels of pesticide (Akkina et al., 2004). 
 
1.5i: Diethylstilbestrol 
 
Diethylstilbestrol  (DES) while not strictly an EDC, provides a good indication 
as to what might be expected from ingestion of exogenous oestrogenic 
compounds.  It is an orally active synthetic oestrogen that was developed in 
1938 as the first easily synthesised and usable oestrogen (Laronda et al., 
2012). DES was subsequently used in the 1940s-1970s in the United States 
and Europe to treat infertility, and to prevent miscarriage during “high risk” 
pregnancies (Bamigboye and Morris, 2003, Laronda et al., 2012, Crain et al., 
2008). The theory was that oestrogen is required to maintain pregnancy, and 
miscarriage is linked to low urine concentrations of oestrogen, therefore 
increasing the concentration of oestrogen, using an antenatal dose of 
synthetic DES, will help maintain pregnancy and reduce miscarriage 
incidences (Smith, 1949). Dr George Van Siclen Smith strongly advised the use 
of DES in pregnancy (Smith, 1949) and his work led to the FDA approval of 
DES to be used to prevent miscarriage in 1947, as reviewed by Laronda and 
colleagues (Laronda et al., 2012).  
However, later studies not only showed that DES was of no benefit to 
pregnancy outcome, but also there were numerous harmful consequences for 
the developing fetus. When the female fetuses reached puberty, they tended 
to have increased genital tract cancers, including rare young-onset clear-cell 
adenocarcinomas (Herbst et al., 1971). DES was the first transplacental 
carcinogen reported (McLachlan, 2006). Female offspring of DES treated 
mothers also experienced significant primary infertility caused by adenosis of 
the vagina and cervix. In utero exposure to DES increased the risk of 
developing endometriosis by 80%, and 5 weeks or more of DES exposure 
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tripled the chance of developing endometriosis compared with those who 
were exposed for less than 5 weeks (Missmer et al., 2004). 
In addition, reproductive system problems were discovered in men who had 
been exposed to DES in utero: high incidence of cryptorchid testes, epidermal 
cysts, hypoplastic testes, abnormal sperm and an increase in testicular 
cancers (Gill et al., 1979, Bamigboye and Morris, 2003). DES was also linked to 
low birth weight in both genders (Bamigboye and Morris, 2003, Laronda et al., 
2012).   
In a rodent model, male mice exposed to DES in utero experienced a higher 
incidence of cryptorchidism, retained Müllerian ducts, abnormal 
spermatogenesis and testicular cancers (McLachlan, 2001). Pregnant rats 
exposed to DES suffered from increased stillbirth, prolonged gestation, 
increased labour time, decreased birth weight, decreased survival post birth 
and an increase in dam adrenal gland weight (Zimmerman et al., 1991). 
 
1.6: EDCs and Male Reproductive Dysfunction   
 
1.6i: Declining Sperm Densities  
 
Male reproductive health is a great concern as human fertility is reported to 
be on the decline. A meta-analysis between 1938 and 1990 published by 
Carlsen and colleagues demonstrated a 19% reduction in semen volume and a 
42% decrease in sperm count (Carlsen et al., 1992). However, the validity of 
these data have been much criticised for numerous reasons including 
inappropriate statistical techniques, differing analysis methods and poor data 
sources, and no accounting for varying study populations (Olsen et al., 1995). 
However, further re-analysis by Swan and colleagues, using linear regression 
models of the original data, and the addition of 47 more studies, suggests that 
mean sperm densities are indeed decreasing in Europe and the United States 
of America, and in fact this new analysis suggests declines have been more 
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rapid than Carlsen and colleagues originally suggested (Swan et al., 1997, 
Swan et al., 2000). Swan and colleagues also interestingly noted the wide 
variation in the geographic distribution of differing sperm densities, 
suggesting a similar aetiology and the requirement for further investigation 
into temporal and environmental variations in sperm health. Additional 
studies have also highlighted the declining sperm densities: Rolland and 
colleagues suggested a significant and continuous decrease in sperm 
concentrations of 32.2% in their French study population over a 17-year 
period (Rolland et al., 2013). However, again, these data were criticised due 
to changes in laboratory practice during the study period (Pacey, 2013). 
Contrasting this, a more recent study suggested a rise in sperm counts, 
worryingly however, only 23% of the young Danish (mean age: 19 years old) 
“general population” participants had optimal sperm concentration and 
morphology (Jørgensen et al., 2012).  
Schiffer and colleagues tested the effects of 96 ubiquitous EDCs on human 
sperm and concluded that EDCs had the capability to impact the CatSper 
channel (within the sperm tail plasma membrane), therefore affecting sperm 
motility due to an increased calcium influx, with possible consequences for 
human fertility (Schiffer et al., 2014).  There is a negative impact of EDCs on 
sperm morphology as shown by Zhang and colleagues who discovered a 
positive correlation between DEHP concentration and spermatozoa 
malformation (Zhang et al., 2006). In a study of healthy men aged 21-40, 
grouped as “infertile” (failure to impregnate their partners within one year 
with regular, unprotected intercourse) or “control” (partners successfully 
conceived within one year), dibutyl phthalate (DBP) and DEHP were detected 
in more than 80% of infertile samples. In addition to this, the concentration of 
DEHP in the fertile men was found to be 0.77μg/mL, compared to a 
concentration of 5.73μg/mL within oligoasthenospermic men (Pant et al., 
2011). A significant negative association was found between DEHP levels and 
sperm motility, and both DEHP and DBP caused a decrease in sperm viability 
in a time and concentration dependent manner (Pant et al., 2011).  
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A review of bovine artificial insemination (AI) records from 1960-1995 have 
demonstrated a reduction in sperm density in bovine semen over the years 
1970 – 1980/5, followed by an improvement thereafter (Wahl and Reif, 2009). 
Although it appears that the overall success of bovine AI is declining, it is 
particularly difficult to interpret data such as these in terms of environmental 
factors because there are so many confounding issues involved in cattle 
breeding, particularly selective pressures and genetic effects (Karoui et al., 
2011). 
 
1.6ii: Testicular Dysgenesis Syndrome  
 
Following the increased awareness of declining sperm quality, widespread 
studies have been completed on the physiological causes of this problem. 
Poor semen quality has now been linked with wider male reproductive 
perturbations, primarily testicular cancer, crypotorchidism, altered anogenital 
distance and hypospadias. The grouping of these conditions is referred to as 
Testicular Dysgenesis Syndrome (TDS) (Skakkebaek et al., 2001). Many of 
these conditions are increasing and there is growing evidence to suggest an 
environmental aetiology (Main et al., 2010). One aspect of TDS is testicular 
cancer, and the most important tumour in this syndrome is germ cell 
neoplasia. Germ cell tumours consist of abnormal primordial germ cells or 
gonocytes, termed carcinoma in situ (CIS) cells, and eventually develop into 
malignant tumours in adolescent and young men (Rajpert-De Meyts et al., 
2003). Indeed, as most of these human male reproductive pathologies can be 
mimicked in experimental animal models by exposure to EDCs in utero or 
during the perinatal period, Skakkebaek and colleagues (2001) suggest that 
TDS is caused by environmental factors, which are affecting embryonic and 
gonadal development. Hu and colleagues reviewed the effects of phthalates 
on Leydig cell development and concluded that although animal studies of 
phthalate exposure show an association with TDS, a human epidemiological 
link between phthalates and TDS is difficult to obtain (Hu et al., 2009). In 
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addition, in utero exposure of rat fetuses to the phthalate diisononyl 
phthalate (DINP) caused fetal Leydig cell aggregation and reduced expression 
of steroidogenic enzymes (Li et al., 2015).  
Despite these observations, a recent review of published epidemiological 
studies has revealed that there is only a weak association between individual 
EDCs and TDS (Kortenkamp et al., 2014). Based on reported tissue levels of 22 
different EDCs, these authors investigated the effects of EDC mixtures in an in 
vitro anti-androgenicity assay system directed at androgen receptor (AR) 
antagonism. Kortenkamp and colleagues failed to show effects at the average 
serum EDC concentrations found in European serum. This study has a number 
of limitations including only investigating 22 out of many thousands of 
potential EDCs, the relevance of adult tissue levels to the in utero situation, 
and the relevance of the in vitro assay endpoint to the in vivo 
pathophysiological situation. For example, the cellular response to selected 
EDCs in vitro is far removed from in vivo responses to an environmentally 
relevant mixture of contaminants. To overcome this problem, more recent 
studies now focus on in vivo models of fetal development and EDC exposure.  
 
1.7: EDCs and Animal Models of Human Exposure  
 
1.7i: Rodent Models 
 
There are no human models of everyday EDC exposure, and therefore the real 
life actions of EDCs have been questioned (Schiffer et al., 2014). However, in 
reality, it is not possible to complete fetal studies of EDC exposure on humans 
for ethical reasons. Limited human studies that have been carried out have 
focussed on first trimester fetal testis tissues (Fowler et al., 2007) and ovary 
tissues (Fowler et al., 2014) obtained from social abortions. Consequently, 
many studies investigating the effects of EDCs have focused on rodent models 
and a single chemical entity, over relatively short time periods at higher than 
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environmentally relevant concentrations (pharmaceutical doses) (Fowler et 
al., 2008). This is very important to enable a broader understanding of the 
mechanisms by which EDCs act; however, these experiments do not follow a 
normal everyday pattern of human or animal exposure. Looking at the effect 
of exposure on whole organisms provides a far greater understanding of 
endocrine disruption. The complexity of a whole organism cannot be 
replicated in vitro, for example, in cell cultures. One example of this 
complicated interaction is that EDCs may interact with steroidogenic 
pathways at each level of the hypothalamic pituitary adrenal axis (Harvey et 
al., 2007). In addition, it is important to address whether or not 
environmental concentrations of chemicals, rather than pharmaceutical or 
toxicological concentrations, elicit negative physiological effects.  
 
AGTR1 
Angiotensin II hormone interacts with the Angiotensin II Receptor, Type 1 
(AGTR1) to regulate aldosterone secretion. Aldosterone, a mineralocorticoid, 
acts upon the distal tubules and collecting ducts within the kidney to retain 
sodium and secrete potassium, and therefore retain fluid, increasing blood 
volume. Maternal EDC exposure during pregnancy has been investigated in a 
variety of animal models using a number of different pathophysiological 
endpoints, with rodents being a commonly used experimental species. For 
example, the offspring of pregnant rats treated with DEHP in utero 
(gestational day 14 until parturition) exhibit a decrease in circulating 
aldosterone but not corticosterone concentrations, and a reduction in adrenal 
AGTR1 expression (Martinez-Arguelles et al., 2011).  The authors conclude 
from their results that in utero DEHP exposure causes reduced adult 
aldosterone concentrations due to a reduction in adrenal AGTR1, and this 
reduction is sufficient to prevent normal physiological angiotensin-II induced 
aldosterone responses. However, these studies only showed a significant 
effect on AGTR1 expression following treatment of pregnant females with at 
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least 100mg/kg/day, and in some cases 500mg/kg/day of DEHP (Martinez-
Arguelles et al., 2011).  Since a final human equivalent dose would be 
approximately 10-40mg/kg/day (Reagan-Shaw et al., 2008), this would not 
appear to be environmentally relevant; the human of average weight is 
unlikely to be consuming 2800mg/day DEHP. Effects of maternal exposure to 
phthalates on the fetal development of the male reproductive system has 
also been investigated in vivo in rodent models with the conclusion that rats 
and mice, and indeed different strains of mice, have a different response to 
maternal phthalate exposure (Johnson et al., 2012).  
While there is a substantial literature relating to the effects of maternal 
exposure to EDCs on various aspects of the endocrine system, these studies 
can be criticised as not reflecting the real life situation because (a) they 
investigate a single chemical entity rather than the complex mixtures found in 
the environment, (b) they have used far higher concentrations of EDCs than 
result from normal environmental exposure, and (c) some of the resulting 
effects appear to be species specific and therefore this approach may be a 
poor model of human exposure.  
 
1.7ii: In vitro Models 
 
In addition to studies on intact animals, a number of in vitro cell or tissue 
culture methods to investigate EDC exposure have been developed. The 
strength of such an approach is that effects of EDCs on specific cell types or 
tissues can be investigated in isolation; the weakness is that such an approach 
does not take into account the interactions that occur between different 
organ systems in vivo and of course such a cell or organ based approach 
cannot be used to investigate the effect of maternal exposure on fetal 
development. Furthermore, the concentrations of EDCs that are utilised in 
such in vitro approaches are generally far greater than the levels of exposure 
of tissues in vivo. For example, Habert and colleagues report significant 
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effects using concentrations of 10-6 and 10-5M of the plasticiser mono-(2-
ethylhexyl) phthalate.  These workers also demonstrated that cultured rat, 
mouse, and human fetal testis implants showed quite different responses to 
individual EDCs according to species (Habert et al., 2014), calling into question 
the usefulness of this approach as a predictor of the effects of the same 
chemicals on different species or as a model of human exposure.  
 
1.7iii: Ovine Models  
 
Agricultural animals provide a realistic model for human exposure to 
numerous toxins and EDCs. They are housed within close proximity to people, 
resulting in similar, but not identical, levels of exposure. In addition, 
ruminants have similar reproductive anatomy, are more similar in weight to 
humans than rodents, and fetal development follows a similar pattern to the 
human (Padmanabhan and Veiga-Lopez, 2014). Ruminant models of exposure 
therefore show insight into the potential perturbations of EDCs on human 
hormonal pathways. Sheep are an “exceptional animal model to study 
developmental programming of adult reproductive disorders” (Padmanabhan 
and Veiga-Lopez, 2014). Given this breadth of application of ovine models to 
the human, the use of such a model for the investigation of environmental 
contamination is likely to be of significant relevance to human health.  
 
In addition to sheep being exceptional models of development for humans, it 
is important to create a model representative of environmental EDC 
exposure, as unlike many investigations of a single chemical entity, the 
environment is contaminated with a complex mixture of EDCs at varying 
concentrations. One useful model in this regard is a real-life ovine model of 
exposure defined by Fowler and colleagues as “exposure through natural 
route, not via specific application such as injection” (Fowler et al., 2008). 
British sheep management systems using human sewage sludge fertiliser have 
been exploited as a highly relevant animal model of human exposure to an 
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environmentally relevant cocktail of EDCs. This has a number of advantages: 
like humans, sheep are long-lived, have a long gestation period (145 +/-5 
days), and organogenesis is similar to humans (Hombach-Klonisch et al., 
2013). They are also relatively available, and act as a human source of EDC 
exposure as humans eat their meat, along with the EDCs found therein.   
 
As mentioned previously, sewage sludge biosolids are increasingly being used 
in animal keeping systems throughout the world as a source of pasture 
fertiliser. It is a by-product of human wastewater treatment, contains a 
cocktail of EDCs and heavy metals, and prolonged usage causes a build-up of 
EDC concentration in the soil (Rhind et al., 2013). Prior to use, it is processed 
to remove some environmental contaminants and pathogens. Using sewage 
sludge as a fertiliser is a preferred alternative method of human waste 
disposal than the alternatives: landfill or deposition into waterways 
(Rockefeller, 2002). However, due to their EDC content, sewage sludge 
fertiliser is now banned for use in certain agricultural practices in Switzerland 
(Wager, 2007). 
An experimental model has been established in which pregnant ewes are 
maintained either on pastures fertilised with sewage sludge, or pastures 
fertilised with an inorganic, EDC-free fertiliser, reflecting the reality of 
environmental contamination. This model also enables the investigation of 
the effects of EDCs within sewage sludge on different windows of 
embryological development of fetuses. The sewage sludge model used in this 
study is currently the only available real-life model of the exposure to an 
everyday cocktail of EDCs.  
In addition to investigating ruminants as a model for human exposure, they 
are also a source of human EDC exposure via their meat. Many EDCs are 
lipophilic and therefore have the capacity to accumulate in adipose tissue; for 
example, EDCs have been detected in beef from cows grazed on 
contaminated pastures (Petro et al., 2010). Furthermore, EDCs are found 
within ruminant milk (Rhind et al., 2007), another source of human exposure, 
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and elevated concentrations of PCBs are linked with higher yielding dairy 
cows compared to lower yielding cows (Petro et al., 2010). This is therefore 
an increasing source of human exposure due to the trend to breed for high 
milk production in the UK dairy industry. Interestingly, breeding for such traits 
has been linked with the increasing infertility issues that are having major 
negative impacts on the UK dairy industry. Fertility in the UK dairy industry is 
decreasing at an alarming rate as indicated by the increasing inter-calf 
interval. Decreasing fertility is partially attributed to increased yields and a 
widespread negative energy balance; however, it is reasonable to assume 
that exposure to environmental EDCs is an additional factor adding to the 
increased infertility seen (Rhind, 2005).   
Studies of maternal and fetal tissues from ewes maintained on EDC containing 
sewage sludge-treated pastures show significant effects on reproductive 
potential in male and female fetuses (Paul et al., 2005). Levels of certain EDCs 
and heavy metals have also been measured in fetuses from the sewage 
sludge model and significant concentrations of copper, lead, zinc and DEHP 
were found (Rhind et al., 2002, Rhind et al., 2005a, Rhind et al., 2005b, Rhind 
et al., 2007). In addition to human EDC exposure from meat consumption, the 
sewage sludge model broadly reflects direct human EDC exposure (Rhind et 
al., 2005b, Rhind et al., 2002).   
 
Ovine Models of Female Pathologies   
 
Ovarian gametogenesis requires a precise combination of oestrogen, inhibin 
and activin locally within the developing fetus, and any interference in this 
could impact upon normal ovarian development. This is concerning as many 
EDCs are known to have oestrogenic properties.  The pool of primordial 
follicles, which constitute the reproductive lifespan of the mammalian female, 
is completed during fetal development in utero. Any disturbance of fetal 
ovarian development could drastically reduce this oocyte pool and, therefore, 
 
 
26 
 
female fecundity, in contrast to the male, which undergoes spermatogenesis 
throughout adult life. Indeed, the ovine sewage sludge models of EDC 
exposure have shown that fetal ovarian development is detrimentally 
affected, as shown by significantly decreased oocyte density compared to 
controls, and significant female fetus growth restriction has been recorded 
(Fowler et al., 2008). In addition, Fowler and colleagues found a trend, 
although not significant, for decreased expression of ovarian CYP17A1 and 
consequently a lower serum oestradiol concentrations in these fetuses, 
suggesting EDCs have the ability to reduce steroidogenesis (Fowler et al., 
2008). Further fetal sheep ovary studies concluded that a change in the 
uterine environment during gestation, even if from a higher than normal EDC 
exposure to zero EDC exposure, is more detrimental than a continual 
exposure to EDCs throughout gestation (Bellingham et al., 2013). In support 
of this, ovaries from sheep fetuses exposed both continuously or transiently 
to sewage sludge during gestation showed fewer ovarian follicles regardless 
of the treatment group (Lea et al., 2014b).  
 
Ovine Models of Male Pathologies  
 
Using the previously mentioned ovine sewage sludge model, Paul and 
colleagues demonstrated marked perturbation in fetal testes development 
(Paul et al., 2005). During this study, testes from 110-day-old fetuses 
exhibited both reduced Leydig and Sertoli cell numbers, which is likely to 
negatively impact spermatogenesis in later life. As described in the female, 
more recent studies indicate that a short transitory period of exposure during 
gestation may be more detrimental than continual EDC exposure throughout 
gestation (Lea RG et al., 2010, Lea et al., 2014b).  These alterations were seen 
in further studies, which extended sewage sludge exposure to include post-
natal contact. Bellingham and colleagues saw reduced testicular germ cell 
numbers and increased numbers of abnormal tubules in a subset of male 
lambs from the exposed groups (Bellingham et al., 2012).  
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1.8: The Hypothalamic Pituitary Gonad and Hypothalamic 
Pituitary Adrenal Axes 
 
As previously mentioned, EDCs have the capacity to affect reproductive 
function in male and female sheep fetuses within the ovine models of 
exposure described above. Although initial studies focussed on the gonads, 
more recent studies have also shown effects on the hypothalamic and 
pituitary components of the HPG Axis. Reproduction in mammals is driven by 
a complex system of hormonal interactions and feedback loops from the 
hypothalamus, pituitary gland and the gonads creating the HPG axis. 
However, the endocrine system operates as an integrated whole, and 
reproduction involves systems other than the HPG axis, including the 
hormones derived from the adrenal gland and therefore the Hypothalamic 
Pituitary Adrenal (HPA) axis. The endocrine system in general, including 
reproductive aspects, is particularly vulnerable to disruption by a variety of 
synthetic environmental EDCs that can interfere particularly with steroid 
hormones, their synthesis, metabolism and receptor binding (Harvey et al., 
2007). Whereas the HPG axis and the influences of EDCs thereon are 
relatively well understood, environmental and toxicological studies on the 
HPA axis have been less well studied. Indeed, Harvey and co-workers stressed 
an urgent need for an “adrenal toxicology assessment strategy” (Harvey et al., 
2007) and the adrenal zona fasciculata, key for glucocorticoid production, is 
reported to be particularly vulnerable  (Plechner, 2004).   
Normal mammalian reproduction relies on a complex neuroendocrine 
pathway illustrated in Figure 3.  Hypothalamic Gonadotropin Releasing 
Hormone (GnRH) results in the release of Luteinising Hormone (LH) and 
Follicle Stimulating Hormone (FSH) from the Anterior Pituitary Gland. These 
then act upon the gonads to stimulate testicular and ovarian maturation, 
steroidogenesis and gametogenesis (Bellingham et al., 2009). Figure 3 
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illustrates the numerous possible sites of EDC interaction from brain to 
gonadal level.  
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1.9: The HPG Axis 
 
Figure 3: A schematic of the hypothalamic pituitary gonadal axis, EDCs have the potential to act upon multiple receptors, or as multiple 
hormones within this axis. 
 
 
 
30 
 
1.9i: The Hypothalamus and Pituitary Gland 
 
As outlined in Figure 3, the HPG axis is regulated by an abundance of 
hypothalamic inputs and is highly sensitive to the activating effects of 
endogenous steroids during fetal life (Robinson et al., 2002). Bellingham and 
colleagues investigated the impact of EDC exposure on ovine fetal 
hypothalami and pituitary glands. In this study, sheep were maintained on 
pastures treated with human sewage sludge fertiliser up to day 110 of 
gestation. This resulted in reduced expression of fetal hypothalamic 
Gonadotropin Releasing Hormone 1 (GnRH1) mRNA and pituitary gland GnRH 
receptor (GnRHR) mRNA (Bellingham et al., 2010).  
The neuropeptide kisspeptin and its receptor, G-protein-coupled receptor 54 
(GPR54), are obligatory for GnRH secretion and therefore normal 
reproductive function (Roa et al., 2008). GnRH levels can therefore be 
affected by alterations in the kisseptin/GPR54 system, and this system may be 
one way EDCs perturb normal reproduction (Navarro and Tena-Sempere, 
2008). Kisseptin expression is regulated by oestradiol (Navarro and Tena-
Sempere, 2008) highlighting another location of possible oestrogenic 
chemical interaction. Indeed Navarro and colleagues showed neonatal 
injection of oestradiol benzoate resulted in reduced expression of 
hypothalamic KiSS-1 mRNA in both male and female rats (Navarro et al., 
2009).  
Bellingham and colleagues also showed that fetal exposure to sewage sludge 
resulted in reduced expression of both kisseptin and GPR54 mRNA expression 
(Bellingham et al., 2009). Early exposure to environmental chemicals with sex 
steroid activities may disrupt gonadotropin secretion in later life, and 
therefore alter reproductive function, due to direct interactions of EDCs and 
the kisspeptin system (Tena-Sempere, 2010).  
In addition, Bellingham and colleagues have shown EDCs can affect the fetal 
pituitary gland. In an ovine study of sewage sludge exposure, fetal pituitary 
 
 
31 
 
glands showed a significant decrease in the number of luteinising hormone 
beta (LHβ) immunopositive cells, and also a significant decrease in double 
labelled LHβ and kisspeptin cells (Bellingham et al., 2009). In addition the fetal 
pituitary showed significantly fewer oestrogen receptor 1 (ER1) positive cells 
and LHβ/ER1 positive double labelled cells (Bellingham et al., 2009). 
Furthermore, ovine fetal hypothalamic and pituitary glands had lower GnRH 
receptor (GnRHR) and galanin receptor (GALR) mRNA expression, and fetal 
hypothalami had lower GnRH mRNA expression, when exposed in utero to 
sewage sludge compared with controls (Bellingham et al., 2010).  
 
1.10: Endocrine Disruption and the HPA Axis 
 
1.10i: Ovine Fetal Adrenal Development and Anatomy 
 
Adrenal glands develop bilaterally at the cranial pole of the mesonephros 
(Tangalakis et al., 1992). During embryonic development, intermediate 
coeleomic mesoderm cells from the urogenital ridge migrate to the gonads to 
produce steroidogenic tissue. The same mesoderm cells also migrate to 
surround the immature adrenal medulla to form the adrenal cortex (Dyce et 
al., 2002). The resulting steroid-producing cells in the gonads and adrenal 
cortex therefore have the same ontogeny (Kaludjerovic and Ward, 2012). In 
addition, the expression of steroidogenic genes appear to be controlled by 
the same transcriptional regulatory promoter (SF1) in adrenal, testis and 
ovary (Buaas et al., 2012). It follows therefore that like gonads, the adrenal 
glands are also likely to be negatively affected by EDCs. 
The anatomy of the adult and fetal adrenal gland is illustrated in in Figures 4 
and 5. Both include a central medulla, which produces catecholamines 
surrounded by a steroid-rich cortex. The adult mature adrenal cortex is split 
into three distinct zones, each producing different classes of steroid 
hormones.  
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Figure 4: A Schematic of basic adult adrenal anatomy: the outer fibrous capsule 
encasing the cortex, the three layers of the cortex: zona glomerulosa, zona 
fasciculata and zona reticularis, the central medulla and central medullary vein.  
 
 
Figure 5: Histological Section (H&E Stain) of an ovine fetal adrenal gland at day 
140 of gestation demonstrating the adrenal layers, including the location of 
the zona reticularis which will not develop until post birth (100x magnification).  
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Ovine adrenal gland development is shown as a timeline in Figure 6. Fetal 
pituitary adrenocorticotropic hormone (ACTH) secretion stimulates the 
development of the fetal adrenal cortex (Matthews and Challis, 1996). 
Subsequently, adrenal epigenesis is as follows: coelomic mesothelial 
epithelium proliferates at the cranial edge of the mesonephros resulting in 
the initial adrenal cortex (Aly, 1978). The cortical area is then invaded by 
migrating sympathochromaffin cells from the sympathetic ganglia, which 
migrate into the centre of the dividing mass, creating the fetal adrenal 
medulla (Boshier and Holloway, 1989). Both the developing medulla and 
cortex are encased by the developing capsule (Aly, 1978). Within the 
developing cortex, wide sinusoids develop and cortical zonation begins from 
the periphery, starting with the outermost zona glomerulosa, followed by the 
zona fasciculata (Boshier et al., 1989), and finally the central section of the 
cortex. The zona reticularis develops after birth; there is no evidence of the 
zona reticularis at two days post-partum (Tangalakis et al., 1992). 
Differentiation of the cortex and medulla is complete by day 100 of gestation 
(Boshier et al., 1989), followed by maturation of the cortical zones (Wintour, 
1984). 
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Figure 6: Timeline of ovine fetal adrenal gland development. Conception at day 0. Black: cortex, Red: medulla development. 1. (Aly, 1978), 2. 
(Tangalakis et al., 1989), 3. (Glickman and Challis, 1980), 4. (Tangalakis et al., 1990), 5. (Wintour, 1984), 6. (Tangalakis et al., 1992), 7. (Boshier and 
Holloway, 1989), 8. (Boshier et al., 1989), 9. (Coulter et al., 2000), 10. (Buckley, 2012), 11. (Han et al., 1997), 12. (Riley et al., 1992). 
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The principle regulators of the HPA axis are corticotropin releasing hormone 
(CRH) and arginine vasopressin (AVP) from the parvocellular division of the 
paraventricular nucleus (PVN) which act synergistically and are released into 
hypophyseal portal circulation (Papadimitriou and Priftis, 2009) to initiate 
ACTH release (Figure 7). In the sheep, CRH mRNA increases throughout 
gestation within the PVN, with a significant increase between day 100/120 
and day 140/143 of gestation.  AVP also increases throughout gestation, and 
AVP mRNA levels within the magnocellular region of the PVN significantly 
increases between 60/80 and 140/143 days of gestation (Matthews and 
Challis, 1995). Matthew and Challis also discovered that hypoxemia, a 
common in utero stressor, caused a significant increase in CRH mRNA, and an 
increase, however not significant, of AVP mRNA within the fetal PVN 
(Matthews and Challis, 1995). 
ACTH is released as the pro-hormones pre-ACTH and pro-opiomelanocortin 
(POMC) from corticotropes within the pars distalis of the anterior pituitary 
gland. POMC cleavage products include α-melanocyte stimulating hormone 
(α-MSH) and β-endorphin, and POMC mRNA increases within the ovine fetal 
pituitary gland late in the second half (days 100-135) of gestation, followed by 
a plateau before the increase for active labour. CRH mRNA also dramatically 
increases just before term, followed by decline post-partum (Matthews and 
Challis, 1996). Prohormone convertase I (PHC I) is found within the pars 
distalis of the pituitary gland, which further breaks down POMC to active 
ACTH (Papadimitriou and Priftis, 2009). ACTH acts directly on the adrenal 
cortex to elicit the release of glucocorticoids. 
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1.10ii: The HPA Axis 
 
  
 
 
 
 
 
 
 
 
 
Figure 7: Schematic of the hypothalamic pituitary adrenal axis. 
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1.10iii:  The Fetal HPA Axis and Parturition 
 
The fetal HPA axis and adrenal gland, and subsequent production of 
glucocorticoids, is essential for brain development, stress responses, 
homeostasis and for the development, maturation and growth of the fetus in 
utero, and parturition (Kaludjerovic and Ward, 2012, Challis et al., 2000). A 
key factor in the reproductive success of mammalian species is this complex 
inter-relationship between the fetal adrenal gland and the maternal 
reproductive system (Kaludjerovic and Ward, 2012). Indeed, disruption of the 
ovine fetal pituitary, adrenal or PVN in utero resulted in prolonged gestation 
(Challis et al., 2000). Therefore, any factor that has a detrimental effect on the 
development of the fetal HPA axis has the potential to cause widespread 
alterations in adult phenotypes, supporting the concept of the fetal onset of 
adult disease. 
Prior to parturition there is a rapid increase in the levels of the glucocorticoid 
cortisol in the fetus in many mammalian species including the human, 
although in rodents the principal glucocorticoid is corticosterone (Matthews 
and Challis, 1996). In sheep there is an exponential increase in fetal plasma 
cortisol levels in the last ten days of gestation following an increase in ACTH: 
the pre-parturient rise. In a negative feedback loop, cortisol reduces the 
production of CRH, AVP and therefore ACTH, however, immediately prior to 
parturition, there is an increase in cortisol, ACTH and CRH, indeed, CRH mRNA 
levels within the PVN is at its highest at late gestation (Matthews and Challis, 
1995). These increases are somewhat counter-intuitive given the known 
negative feedback control of ACTH/CRH/AVP by glucocorticoids.  
However, there are a number of factors that are thought to attenuate this 
negative feedback control, as can be seen in Figure 8 below. During gestation 
there is an opposing effect of ACTH, which is stimulatory in regards to cortisol 
production, and the larger molecular weight ACTH precursors POMC and pre-
ACTH, which are inhibitory on the fetal adrenocortical cells. The secretion 
rates of these inhibitory factors decrease relative to ACTH by a factor of two 
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during late gestation, potentially contributing to the increased cortisol 
production during this time (Schwartz and McMillen, 2001, Matthews and 
Challis, 1996, Challis et al., 2001). The increase in fetal plasma cortisol reduces 
the expression of glucocorticoid receptors in the hippocampus, PVN (site of 
CRH and AVP release) and the anterior pituitary (site of ACTH and pro-
hormone release) (Kapoor et al., 2006). The mRNA of pituitary receptors for 
CRH also decreases by approximately 40% from gestational days 102/105 to 
137/139 (Schwartz and McMillen, 2001). Factors such as these may allow an 
increase in ACTH in the presence of increased cortisol during this period, 
maintaining the high cortisol level required for parturition.  
In addition to fetal CRH production, the cortisol surge in both sheep and 
humans may be sustained by the additional placental CRH (Hamlin and 
Guillette, 2011). There are other factors that influence ACTH production 
including oxytocin (inhibitory), opiates (which supress CRH release), 
urocortins (which bind to CRH receptors), endocannabinoids (reduce basal 
stimulation of ACTH), and suppressor of cytokine signalling-3 (SOCS3) (inhibits 
POMC production and ACTH secretion), as reviewed by Papadimitriou and 
Priftis (Papadimitriou and Priftis, 2009). 
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 Figure 8: The Role of the hypothalamic pituitary adrenal axis in ovine 
parturition 
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In addition to pre-term activation of the fetal HPA axis, and the consequential 
cortisol surge, the maternal body has to be transformed for the impending 
labour. Simultaneously to the cortisol surge, the placenta increases the 
expression of CYP17A1 enzyme, which promotes placental progesterone 
conversion to androstenedione, therefore reducing progesterone levels 
(required for pregnancy maintenance) immediately prior to the 
commencement of labour, and increasing oestrogen production, which leads 
to the transformation of the uterus and cervix into the labouring state (Challis 
et al., 2001). 
In addition to the glucocorticoids, the fetal HPA axis is controlled by a number 
of other factors including prostanoids (including prostaglandins) synthesised 
in the fetal brain. Hippocampal glutamate receptors stimulate prostaglandin 
endoperoxide synthase (PGHS2), also termed cyclooxygenase 2 (COX2), 
leading to an increase in prostaglandin-E2 (PGE2) which increases fetal HPA 
axis activity and subsequent cortisol levels (Reimsnider and Wood, 2006). This 
is hypothesised to be an additional mechanism to overcome negative 
feedback of cortisol in late gestation. In addition, fetal glucocorticoids up 
regulate PGH2S mRNA within the placenta, further activating the fetal HPA 
axis (Challis et al., 2001). Inhibition of PGHS2, for example by using non-
steroidal anti-inflammatory drugs (NSAIDs), delays the start of labour 
(McKeown et al., 2000). The myometrium, which becomes increasingly 
activated by stretching caused by growth of the fetus, remains quiescent until 
the time of birth by the action of increased levels of progestagens (Fowden et 
al., 2008).  
Studies have shown that the developing HPA axis is sensitive to 
environmental factors, including prenatal stress, and either experimental or 
natural stress situations such as exposure to predators in the wild, leading to 
raised cortisol levels during pregnancy. Exposure to excess levels of cortisone 
during fetal development can result in exacerbated stress responses 
subsequently in adult life (Lund et al., 1988). The adrenal gland itself is 
particularly vulnerable to environmental and toxic insults due to it being so 
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highly vascularised (Hinson and Raven, 2006). In addition, certain PCBs reduce 
plasma cortisol levels (Zimmer et al., 2013), and Zimmerman and colleagues 
showed  that exposure of rats to DES caused delayed parturition and a 
prolonged labour time (Zimmerman et al., 1991) demonstrating gestational 
effects from oestrogenic EDCs. 
 
1.10iv: Ovine Pregnancy Maintenance 
 
The maintenance of pregnancy depends upon progesterone. Sufficient 
production of oestrogen by the placenta is required near term, which in turn 
depends upon the synthesis of dehydroepiandrosterone (DHEA) and its 
sulpho-conjugate DHEAS, ultimately from cholesterol via pregnenolone. The 
17alpha-hydroxylase (CYP17A1) enzyme which catalyses the conversion of 
pregnenolone to DHEA and then DHEAS, while absent from the placenta, 
shows a high level of expression in the primate fetal adrenal cortex 
(Kaludjerovic and Ward, 2012, Mesiano and Jaffe, 1997, Labrie, 1991). Indeed, 
DHEA and DHEAS are the most abundant adrenal hormone in humans (Ikeda 
et al., 2012). Fetal adrenal glands from lower mammals, including sheep, 
produce relatively less DHEA and DHEAS than humans (Labrie, 
1991).   However, the fetal adrenal gland is essential in maintaining the 
required oestrogen levels for pregnancy maintenance by supplying the 
majority of the DHEA that the placenta requires for oestrogen synthesis. 
Some DHEA is also provided by the mother, but to a lesser extent, as can be 
seen in Figure 9 below (Kaludjerovic and Ward, 2012). There is a negative 
feedback system whereby increasing levels of plasma oestrogen suppresses 
the responsiveness of the fetal adrenal to ACTH (Albrecht and Pepe, 1995), 
lowering the production of DHEA and thereby reducing placental oestrogen 
synthesis, thus generating the potential for interference by EDCs, particularly 
oestrogenic compounds, in this feedback control system. However, placental 
oestrogen also can exert a positive feedback response, up-regulating 11-beta-
hydroxysteroid dehydrogenase (11βHSD) promoting conversion of cortisol to 
 
 
42 
 
(inactive) cortisone, which stimulates fetal pituitary ACTH production and 
consequently an increase in DHEA (Albrecht and Pepe, 1999). 11βHSD mRNA 
within the pars distarlis of the fetal pituitary gland increases near term 
(Matthews and Challis, 1996). It follows therefore that environmental factors 
that inhibit CYP17A1 and/or 11βHSD enzymes will impact on essential 
pregnancy maintenance pathways dependent on the regulation of oestrogen 
and glucocorticoids. 
Although the phytoestrogens genistein and daidzein (found in soy protein) 
have been reported to increase production of DHEA and DHEAS via inhibition 
of 21-hydroxylase in post-natal and adult adrenal cells (H295) cultured in 
vitro, there was no effect of these compounds on DHEA or DHEAS production 
by cultured fetal adrenal cells (Mesiano et al., 1999). The relevance of such 
cell-based in vitro culture systems to the physiology of the intact animal is 
uncertain as previously mentioned. 
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Figure 9: The inter-relationship between fetus and 
pregnancy maintenance. The placenta lacks the 
necessary CYP enzyme to produce the precursors of 
oestrone, oestradiol and oestriol, which are essential 
for pregnancy maintenance. Adapted from 
(Kaludjerovic and Ward, 2012). 
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Although there are clear endocrine communication pathways between the 
fetal adrenal and the placenta, there are some important species differences. 
The sheep fetal adrenal contains a high level of CYP steroidogenic enzymes 
and is steroidogenically active in early pregnancy as well as from 15-20 days 
before parturition (Zimmerman et al., 1991, Tangalakis et al., 1990). Effective 
sheep fetal adrenal gland steroidogenesis is linked to fetal catecholamine 
secretion since fetal cortisol is important for differentiation of the medulla 
and subsequent epinephrine secretion (Boshier et al., 1989, Boshier and 
Holloway, 1989). In early pregnancy, the sheep fetal adrenal cortex secretes 
lower levels of the oestrogen precursor dihydroepiandrosterone (DHEA) than 
its human counterpart, due to the lack of a prominent ‘fetal’ zone 
(undeveloped fetal adrenal cortex found in primates) and low levels of 
CYP17A1 (Labrie, 1991). However, preterm activation of the ovine fetal HPA 
axis stimulates CYP17A1 expression and thus adrenal cortisol production and 
placental progesterone conversion to androstenedione and oestrogen, which 
together transform the uterus and cervix to the labouring state and 
coordinate fetal organ system maturation with birth (Han et al., 1997, 
Tangalakis et al., 1989).  Lambs adrenalectomised in utero display delayed 
parturition and post-natal over maturation (Drost and Holm, 1968). The 
similarities between the sheep and human adrenal development, including 
the pre-natal cortisol surge make the sheep a relevant model for HPA toxicity, 
and therefore EDC studies (Zimmer et al., 2013), especially as both sheep and 
humans produce cortisol, whereas rodents produce corticosterone due to the 
lack of DHEA and DHEAS (Challis et al., 2001, Martinez-Arguelles et al., 2014). 
 
1.11: EDCs and Steroidogenesis 
 
Successful development of the HPA axis is essential for adrenal glucocorticoid 
production, and therefore maturation of the fetus and parturition. However, 
the adrenal gland is the most sensitive level of the HPA and the neglected 
organ in endocrine disrupting research (Harvey et al., 2007). It contains a high 
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concentration of cytochrome P450 (CYP) enzymes, which are required for all 
steroid hormone synthesis from their precursor cholesterol (Figure 10). The 
CYP-subfamily of enzymes are monooxygenases, and are important targets 
for EDCs (Miller, 1988). Numerous organs within the body have the capacity 
to produce active steroid hormones; the gonads, placenta, brain, adipose 
tissue but most importantly, the adrenal gland (Sanderson, 2006).  
In outline, the de novo steroidogenic pathway involves a series of enzymes 
that result in the bio-synthesis of steroid hormones from cholesterol including 
progestagens, oestrogens, androgens and glucocorticoids (Figure 10). A 
number of these are CYP enzymes, and the first step in steroid hormone 
biosynthesis involves the conversion of cholesterol to pregnenolone by 
mitochondrial CYP11A1. Pregnenolone is then converted to progesterone by 
3-beta-hydroxysteroid dehydrogenase (3βHSD), which is found in both 
mitochondria and smooth endoplasmic reticula. Pregnenolone and 
progesterone are then the precursors for all further steroid hormones 
(Sanderson, 2006). Initially, external stimuli, including ACTH and angiotensin-
II, activate steroidogenic acute regulatory protein (StAR) and steroidogenic 
factor-1 (SF-1), which induce the steroid synthesis pathway (Stocco, 2001). 
Steroid 21 hydroxylase (CYP21), is unique to the adrenal cortex and is 
essential for the synthesis of the intermediates 11-deoxycorticosterone and 
11-deoxycortisol for mineralocorticoid and glucocorticoid production, and is 
found in all three layers of the adrenal cortex. 11-deoxycorticosterone is 
converted to the mineralocorticoid aldosterone by the enzyme CYP11B2 and 
11-deoxycortisol is converted to the glucocorticoid cortisol by the enzyme 
CYP11B1 (Sanderson, 2006).  
In other steroidogenic organs, for example the testis, the weakly androgenic 
androstenedione, derived from progesterone by the action of CYP17A1, is 
converted to testosterone by 17-beta-hydroxysteroid dehydrogenase 
(17βHSD). CYP17A1 is bi-functional and has both 17, 20, lyase activity 
(required for androgen production) as well as 17, hydroxylase activity 
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(required for glucocorticoid intermediates and androgen synthesis) (Kitamura 
et al., 1991). In the ovaries, androstenedione and testosterone are converted 
to oestrone and oestradiol by aromatase (CYP19) and 17βHSD, 17βHSD types 
1 and 7 favouring the conversion of oestrone to oestradiol (Sanderson, 2006).  
Environmental effects on adrenal development and/or function may occur 
through alterations in CRH and ACTH secretion or at the level of the adrenal 
gland through altered steroidogenic enzyme activity (Kaludjerovic and Ward, 
2012). Indeed, the gestational exposure to PCB congeners present in sewage 
sludge reduces ovine fetal cortisol levels and fetal adrenal size (Hatano et al., 
1996). EDCs have also been linked to adrenocortical hyperplasia in seals 
(Bergman, 1999). In addition, PCBs have been found to alter growth, adrenal 
development and cortisol production in an ovine model of exposure (Zimmer 
et al., 2013). Zimmer and colleagues also found exposure to PCB congeners 
during gestation resulted in excessive and prolonged plasma cortisol levels 
when subjected to mild stress in offspring at nine months old, compared with 
controls (Zimmer et al., 2009). Human adrenocortical cell lines (H295R cells) 
showed increased cortisol production when exposed to an environmentally 
relevant EDC exposure, and multivariate analysis concluded this was due to 
PCB and, to a lesser extent, DDT mixtures. Additionally, increases in 
steroidogenic enzyme mRNA was also detected (Zimmer et al., 2011).  
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1.11i: The Steroidogenic Pathways 
 
Figure 10: Schematic of the steroidogenic pathways 
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1.12: The Effects of Toxicological and Environmental Factors on 
the Adrenal Gland 
 
1.12i: The Case of Pharmaceutically Induced Addisonian Crisis  
 
Licensed pharmaceuticals have the ability to induce fatal adrenocortical 
toxicity, for example, etomidate, the anaesthetic induction agent, quickly 
induces fatal adrenocortical insufficiency (Addisonian crisis) by CYP11B1 
inhibition, and the antidepressant and sedative aminoglutethiamide causes 
inhibition of CYPs 11A1 and 11B1, and MC2R receptor down-regulation 
(Harvey, 2014). Since both EDCs and pharmaceutical drugs inhibit the same 
target genes this raises concerns over the downstream clinical consequences 
of a more subtle perturbation. 
 
1.12ii: Hyperadrenocorticism 
 
Hyperadrenocorticism (HAC) or Cushing’s disease is one of the most common 
endocrine diseases found in the companion dog (Behrend and Kemppainen, 
2001). There are two main forms, the most common being pituitary 
dependent hyperadrenocorticism (PDH), where a benign pituitary 
microadenoma produces excessive levels of ACTH without being affected by 
the increasing levels of glucocorticoid being produced: there is no effective 
negative feedback. This results in adrenal cortical hyperplasia. The second, 
and less common cause of HAC results from high cortisol concentrations 
being produced by a malignant or benign adrenal tumour (adrenal dependent 
hyperadrenocorticism, ADH). It has been hypothesised that such adrenal 
pathology is likely to be caused by environmental toxins (Plechner, 2004). 
Many have hypothesised that xenobiotic chemicals in the environment are 
having negative impacts on wildlife populations, in terms of reproductive 
health and endocrine related problems. A declining population of Baltic grey 
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seals and the ring seal population has been linked to high tissue 
concentrations of PCBs and DDT, which has resulted in reproductive 
pathology and adrenocortical hyperplasia, or Cushing’s Disease (Bergman, 
1999). Cushing’s disease is thought to be a common problem in the Baltic Seal 
population. In seals, DDD metabolites showed marked binding to the adrenal 
cortex, via CYP interaction, which could be a route of adrenal dysfunction and 
hyperplasia reported in these animals (Bergman, 1999).  
 
1.12iii: Metabolic Diseases 
 
There is increasing evidence that fetal exposure to EDCs, especially steroid-
mimicking EDCs, may lead to the development of chronic disease in adult life 
including metabolic diseases such as diabetes and obesity, both of which are 
on the increase. It has been documented since the 1970s that fetal exposure 
to chemicals including testosterone during early and mid-gestation induces 
masculinisation and virilisation in females in a dose-dependent manner, as 
reviewed by Padmanabham and colleagues (Padmanabhan and Veiga-Lopez, 
2014). In addition to causing infertility, prenatal testosterone exposure 
(pregnant ewes were directly injected with testosterone proprionate twice 
weekly from day 30 of gestation) has been shown to cause intrauterine 
growth restriction including decreased fetal weight, reduced head and chest 
circumference, and reduced organ weights in female fetuses (Steckler et al., 
2005). However, as testosterone proprionate was injected at toxicological 
concentrations, this is evidence of developmental origins of abnormalities 
rather than of EDCs causing diseases. However, certain EDCs have known 
androgenic properties and could therefore lead to similar abnormalities.  
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Obesity  
 
In the Western World, obesity is increasing at an alarming rate, and even 
though most suggest this is due to a positive energy balance, there is 
increasing evidence of an additional environmental aetiology, including links 
to EDCs, as reviewed by Grun and Blumberg (Grun and Blumberg, 2009). 
Adipose tissue is not only the site for lipid storage, but functions as an 
endocrine organ and there is an ever-increasing list of obesogens, or 
chemicals that promote lipid accumulation. A number of EDCs have been 
found to act upon the PPAR receptors (peroxisome proliferator activated 
receptors, α, δ and γ). PPARs are nuclear receptors that have multi-functional 
activities including regulation of adipogenesis, involvement in glucose 
homeostasis and lipid metabolism. PPARγ regulates adipogenesis, and the 
diabetic treatments, the thiazolidinediones, cause the production of more 
adipocytes and therefore weight gain, via activation of PPARγ, as reviewed by 
Schug and colleagues (Schug et al., 2011). Schug and colleagues therefore 
hypothesise than any chemical with the capacity to activate PPARγ might 
have the same obesogenic effect. Indeed, the presence of a mutated version 
of PPARγ2 is significantly correlated with obesity (Ristow et al., 1998). 
However, a hypomorphic variant of PPARγ is associated with lower body mass 
and improved insulin sensitivity (Grun and Blumberg, 2009).  Indeed, 
tributyltin, the persistent organic pollutant EDC, is an agonist of retinoid X 
receptors and PPARγ, and studies have shown this dual agonism by tributyltin 
leads to modulation of pro-adipogenic gene networks within liver, adipose 
tissue and bone marrow, as reviewed by Grun and colleagues (Grun and 
Blumberg, 2009). In addition, many other EDCs have been identified as 
ligands for PPARγ, including bisphenol A derivatives (Riu et al., 2011).  
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Metabolic Syndrome 
 
Metabolic syndrome comprises obesity, type II diabetes, dyslipidaemia and 
hypertension, and is endemic in the Western World (Gluckman and Hanson, 
2004). There are five hypotheses for the cause of metabolic syndrome: 1. 
Mitochondrial dysfunction; 2. Thrifty phenotype (able to gain weight quicker); 
3. Epigenetic thrifty genotype; 4. Over-eating and little exercise; 5. EDCs (Kim 
and Lee, 2014). Kim and Lee reviewed EDCs as causes of mitochondrial 
dysfunction, and concluded that environmental chemicals, which are toxic to 
the mitochondria and therefore cause mitochondrial dysfunction, will 
predispose humans to metabolic disease development (Kim and Lee, 2014). 
Lee and colleagues reviewed correlations between POPs and obesity and type 
II diabetes, and concluded that background exposure to mixtures of POPs can 
increase the risk of type II diabetes in humans (Lee et al., 2014).  A major 
economic study conducted in the EU by an expert panel evaluated exposure-
outcome relationships between certain EDCs and obesity and diabetes 
reviewing numerous longitudinal epidemiological studies. Legler and the 
panel concluded DDE exposure cost €24.6 million in 2010 in obesity in 10-
year-old old children and €835 million caused by adult diabetes. Phthalate 
exposure was predicted to cause €607 million in female diabetes associated 
costs, and prenatal BPA exposure was associated with a lifetime cost of €1.54 
billion due to early childhood obesity. In total, EDC exposure associated 
obesity and diabetes is predicted to cost the EU €18-29 billion annually (Legler 
et al., 2015).  
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1.13: Hypothesis 
 
Exposure to Endocrine Disrupting Compounds during fetal life perturbs the 
development of the adrenal gland, which could modify the functionality of 
the hypothalamic pituitary adrenal axis in adult life. 
 
1.14: Aims 
 
The current study is designed to use the ovine sewage sludge real-life model 
of exposure to a mixture of EDCs, to determine the following:  
1. The effects of EDCs in sewage sludge on adrenal gland morphology 
and the expression of functional gene products (steroidogenic 
enzyme: CYP17A1 and receptor: angiotensin-II receptor 1, AGTR1) by 
immunohistochemistry.  
2. The effects of exposure to sewage sludge on ovine fetal adrenal gland 
steroidogenic enzyme and receptor genes by qPCR. Specifically the 
expression of enzymes CYP11A1, CYP17A1 and 3βHSD and the 
receptors oestrogen receptor 1 (ER1), melanocortin receptor 2 (MC2R) 
and AGTR1. 
3. To compare the effects of continuous exposure to EDCs throughout 
gestation to selected transient periods of exposure to the same EDCs. 
This will enable adrenal EDC sensitive windows to be identified in 
terms of the parameters listed in (1) and (2). 
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2. Materials and Methods 
 
2.1: Sewage Sludge Model 
 
Tissues used in these experiments were from animals used in a previous study 
performed at the James Hutton Institute, Aberdeenshire. All animals used in 
that study had been treated humanely according to the James Hutton 
Institute’s Local Ethical Committee. Ewes were maintained at the Macaulay 
Land Use Research Institute research station, Lanarkshire, on pastures that 
had never previously been treated with sewage sludge. The pastures involved 
in this study were treated in the September of the service year with one 
single application of 2.25 tonnes of dry matter per hectare of thermally dried 
sewage sludge pellets. Control pastures were treated with 225kg per hectare 
per year of inorganic fertiliser to achieve similar nitrogen levels to the treated 
pastures. Experimental animals were maintained on the control pastures 
when they were not subjected to treatment exposure (see Figure 11). Grass 
sward in the control and treated pastures was maintained at the same height 
by the addition or removal of non-study sheep. After sewage treatment, the 
pastures were left for three weeks before grazing commenced, a legal 
requirement. No additional feed was given to the sheep throughout the study 
period.  
Initially, 90 Texel ewes were included in the study, and these were weighed 
and their body condition score was measured prior to allocation into the five 
study groups, to enable nutritional standardisation throughout the groups. 
Ewes were euthanised at day 140 of the 147-day gestation period and fetuses 
collected. Four of these groups were maintained on sewage-fertilised 
pastures, and one group was maintained as the control on inorganic fertiliser 
treated pasture (Figure 11). Fifty soil samples of approximately 5cm in 
diameter and 5cm in depth were collected at the beginning of exposure and 
analysed for selected EDCs by the James Hutton Institute to provide an index 
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of animal exposure (data not shown, (Rhind et al., 2005a). Ewes underwent 
oestrous synchronisation with progestagen sponges (Chronolone, 30mg; 
Intervet, Cambridge, UK) before mating. Gestational age was based on 
conception occurring within 48 hours of sponge removal, as previously 
described by Fowler and colleagues (Fowler et al., 2008). 
 
 
 
 
 
 
Figure 11: Exposure of pregnant ewes to sewage sludge fertiliser: experimental 
design. Ewes were randomly allocated to one of five treatment groups. Four of 
the treatment groups comprised ewes exposed to sewage sludge based 
fertiliser (indicated in yellow). One group of ewes was exposed continuously 
(0-140 days) and the remaining three groups were exposed for 80-day periods 
of gestation (early: 0-80 days, mid: 30-110 days and late: 60-140 days).  
Control ewes were maintained on inorganic fertiliser-treated pasture from 0 to 
140 days. All ewes were maintained on inorganic fertiliser treated pastures 
when they were not in their treatment window (indicated in white).  All ewes 
were euthanised at day 140 and fetal tissues were collected. "n" indicates 
number of fetuses collected from each treatment group.  
 
2.2: Tissue Collection 
 
All ewes from each treatment group were euthanised in 2008 at day 140 of 
gestation following United Kingdom Animals (Scientific Procedures) Act, 1986 
Schedule 1 protocols. No animals in this study required Home Office 
Licencing. At euthanasia, maternal body condition score, fetal body weight 
and fetal anogenital distance were recorded. Blood and many tissues were 
collected from both dams and fetuses. Only fetal adrenal glands were used in 
this study. The left fetal adrenal glands were snap frozen in liquid nitrogen 
and stored at -80°C until simultaneous RNA, DNA and protein extraction was 
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carried out. The right fetal adrenal glands were fixed in Bouin’s Solution 
(Sigma-Aldrich, Dorset, UK), and stored in 70% ethanol (Fisher-Scientific, 
Loughborough, UK) at 4°C until further processing was performed.  
 
2.3: Tissue Processing 
 
Processing for immunohistochemical and morphological analysis took place in 
2014. By this time a number of specimens had dried out. Each adrenal gland 
was cut transversely approximately in half, placed in plastic cassettes and wax 
embedded into paraffin using a Leica TP1020 Tissue Processor (Leica 
Biosystems, Newcastle, UK). An established protocol was used during which 
samples were submerged consecutively in 70%, 80% and 95% ethanol, each 
for one hour and then finally in 100% ethanol for two hours. This was 
followed by three hours in Histoclear (Scientific Laboratory Supplies Ltd. 
Hessel, UK), followed by two-and-a-half hours in liquid paraffin.  Once tissue 
processing was completed, the samples were embedded into wax blocks, 
ensuring the cut side of the adrenal gland was accessible for sectioning.  
Sections of adrenal gland were cut to 5µm thick using a Leica Microtome 
(Leica Biosystems, Newcastle, UK) placed onto Polysine slides 
(ThermoScientific, Hamel Hepstead, UK), and dried on a 42°C hot plate. 
 
2.4: Histological Analyses 
 
Slides were stained following the standard haematoxylin and eosin staining 
method, and mounted with a mixture of distyrene, a plasticiser, and xylene 
(DPX) (VWR International Ltd. Lutterworth, UK) under a glass cover slip (VWR 
International Ltd. Lutterworth, UK). 
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2.4i: Immunohistochemistry: Manual Bench Method 
 
Immunohistochemical staining was completed for the steroid enzyme 
CYP17A1 using polyclonal rabbit anti-CYP17 antibody (Biorbyt, Cambridge, 
UK), and the membrane-bound receptor AGTR1 using polyclonal rabbit anti-
AGTR1 antibody (Abcam, Cambridge, UK). A manual bench method was 
initially used. Five-µm sections were submerged in histoclear for five minutes 
and, following wax removal sections were re-hydrated in 100%, 95% and 75% 
ethanol, consecutively for five minutes. Slides were then washed in distilled 
water for two five-minute time periods, followed by two five-minute washes 
in Phosphate Buffered Saline (PBS) buffer solution (Gibco by Life 
Technologies, Paisley, UK). The antigen retrieval step involved 15 minutes of 
microwave treatment at low-medium power in pH6 citrate buffer (Sigma-
Aldrich, Dorset, UK). This treatment was split into three five-minute time 
blocks, with a one-minute rest period in between each. The slides were then 
rested in the hot citrate buffer for 20 minutes. Slides were washed in PBS 
buffer for five minutes, followed by five minutes in an endogenous peroxidase 
blocking solution (3% H2O2: Sigma-Aldrich, Dorset, UK) in distilled H2O, 
followed by two five-minute buffer washes in PBS. Slides were transferred 
into a humidified box. Immunohistochemical staining was carried out using a 
Vectastain Universal Elite ABC kit (Vector Laboratories, Burlingame, USA). 
Sections were incubated with normal blocking serum for 20 minutes, ensuring 
the sample was completely covered. Primary antibody was added to the slide, 
a coverslip applied, and left to incubate at 4°C overnight. The coverslips were 
floated off using PBS with the addition of Tween20 (Merck, Germany) (100µl 
Tween20 per litre of PBS) (PBS/T). This was followed by two five-minute PBS/T 
washes. The secondary biotinylated antibody (Vector kit) was then added and 
incubated at room temperature for 30 minutes. After washing the slides in 
two five-minute PBS/T washes, an avidin biotinylated horseradish peroxidase 
macromolecular complex was added (Vector kit), and incubated at room 
temperature for 30 minutes. Following two five-minute PBS/T washes, 
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diaminobenzidine (DAB) chromogen (DAB Substrate Kit for Peroxidase, Vector 
Laboratories, Burlingame, USA) was added to each slide at 30-second 
intervals to ensure the time on each slide was exactly matched. When a 
colour change was observed (2-10 minutes), the reaction was stopped by 
immersion in in distilled water. Following two five-minute washes in distilled 
water, slides were counterstained with haematoxylin for 25 seconds. After a 
thorough wash in distilled water, sections were dehydrated through ethanol 
(two minutes each in 70%, 95% and 100% ethanol consecutively) submerged 
in xylene for five minutes and cover-slipped with DPX.   
 
Optimisation: anti-AGTR1 
 
To optimise the concentration of primary antibody, one concentration above 
and below the recommended concentration (taken from the antibody data 
sheet) was used. Dilutions used are shown in Table 1 below. Fifty-µL of 
diluted antibody was required per slide. Adult ovine liver tissue was used as a 
positive control.  
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Tissue Anti-AGTR1 antibody 
Concentration  
 
Liver (positive control) 
20 µg/mL 
10 µg/mL 
5 µg/mL 
  
 
Adrenal  
20 µg/mL 
10 µg/mL 
5 µg/mL 
Table 1:  Working concentrations used to optimise anti-AGTR1 antibody for 
immunohistochemical staining 
 
Optimisation Results 
 
Optimal results were obtained at 10µg/mL with DAB staining taking 
approximately six minutes. Negative isotype controls comprised sections 
incubated with non-specific Rabbit IgG (Vector Laboratories, Burlingame, 
USA) at the same concentration as the primary antibody for each IgG 
concentration tested.  
 
Optimisation: anti-CYP17A1  
 
To optimise the concentration of CYP17A1, a range of concentrations was also 
tested (Table 2). Fetal ovine testis was used as the positive control.  
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Tissue Anti-CYP17A1 antibody 
Concentrations  
 
 
Testis (positive control) 
5 µg/mL 
2.5 µg/mL 
1.25 µg/mL 
0.625 µg/mL 
  
 
 
Adrenal 
5 µg/mL 
2.5 µg/mL 
1.25 µg/mL 
0.625 µg/mL 
Table 2: Working concentrations used to optimise anti-CYP17A1 antibody for 
immunohistochemical staining 
 
Optimisation Results  
 
The optimal concentration of anti-CYP17A1 was found to be 5µg/mL, with 
DAB applied for approximately nine minutes. Isotype controls (Rabbit IgG) 
were completed as for anti-AGTR1.  
 
2.4ii: Leica-BOND Max 
 
Since some variability in colour was observed between manual runs, an 
automated staining method was used for better standardisation. Polysine 
slides, mounted with paraffin embedded adrenal gland 5μm sections, were 
stained using a fully automated Leica-BOND Max machine (Leica BOND Max 
machine, Leica Biosystems, Milton Keynes, UK). The standard programme IHC 
procedure X was used comprising a bake and dewax step and heat-induced 
Epitope Retrieval (HIER) step with Bond ER (epitope retrieval) solution 1 
(citrate buffer pH 6.0). The optimal concentration of antibody for 
immunostaining using the automated method was found to be 5µg/ml for 
both anti-AGTR1 and anti-CYP17A1 antibody. Corresponding isotype controls 
(Rabbit IgG) were used at the same concentrations as the primary antibodies, 
and were negative at this concentration. Each run included positive and 
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negative controls (Table 3). Two identical adrenal gland sections were 
incubated with primary antibody in each run as an intra-run control. 
Following completion of staining, slides were dehydrated through 70%, 90% 
and 100% ethanol for two minutes each, followed by mounting in DPX.  
 
AGTR1 CYP17 
Ovine liver: anti-AGTR1 Ovine testis: anti-CYP17 
  
Adrenal: rabbit IgG x 3 Adrenal: Rabbit IgG x 3 
Repeat adrenal x 2 Repeat adrenal x 2 
Table 3: Controls for AGTR1 and CYP17A1 immunostaining.  
 
2.4iii: Image analyses  
 
Approximately eight images of each adrenal were taken with a Leica CTR5000 
Light Microscope (Leica Microsystems (UK) Ltd, Milton Keynes, UK) at 50x 
optical zoom, and stitched together using Leica Application Software, version 
3.8 (Leica Microsystems (UK) Ltd, Milton Keynes, UK) (Figure 12A). Stitched 
images were then analysed for percentage area stained using Image-ProPlus 
software (Media Cybernetics, Inc., MD, USA). Initially, the area of interest was 
highlighted by drawing a line around the capsule, then the DAB-stained area 
was superimposed with red, and the haematoxylin-stained area 
superimposed with yellow (Figure 12B). The percentage area stained by DAB 
was then calculated.  This was completed for both CYP17A1 and AGTR1.  
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Percentage Area Stained  
 
 
 
 
 
 
 
 
Figure 12: A: cross-section image of a typical adrenal gland stained for anti-
CYP17A1. B: image analysis in which the DAB stained area has been highlighted 
in red and the haematoxylin stained area has been highlighted in yellow. 
Magnification: 50x. 
 
The cortical thickness stained by both anti-AGTR1 and anti-CYP17A1 antibody 
was measured using calibrated images and Image-ProPlus software, as 
illustrated in Figure 13. Eight measurements were taken at regular intervals 
around the “clock-face” of the adrenal, and a mean value calculated.  
 
  
A B 
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Cortical Thickness 
 
 
Figure 13: Representative image for AGTR1 immunostaining from which the 
thickness of the cortical stained region was measured using calibrated images 
and Image-ProPlus software. Red line shows an example measurement. Scale 
bar = 200μm. 
 
2.5: Molecular Analyses 
 
2.5i: Tissue Disruption and Homogenisation 
 
Snap frozen left adrenal glands were weighed and homogenised in RLT lysis 
buffer (Qiagen, Crawley, UK.), a highly denaturing buffer containing 
isothiocyanate, which inactivates DNases, RNases and proteases. Twenty-µL 
of RLT buffer was used per 1mg of adrenal tissue. Ten-µL of β-
mercaptoethanol (βME: Sigma-Aldrich, Dorset, UK) per mL of RLT was added 
to the lysis buffer; this was used to reduce R-S-S-R bonds in proteins, and also 
it acts as an antioxidant. After weighing the fetal adrenal glands, each was 
quartered to accommodate their relatively large size. Each quarter was placed 
into a 2mL RNase-free microcentrifuge tube with 600µL of the RLT/βME 
solution. Using a 2mm steel ball, the tissue was then homogenised using a 
bead-milling machine (frequency 30Hz: Scientific Laboratory Supplies Ltd, 
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Hessel, UK) for two minutes. The direction of the tubes was changed and 
homogenisation was then repeated for further two minutes. The lysates from 
all adrenal quarters were combined in a larger 5mL RNase-free Eppendorf 
tube, and the volume adjusted with RLT/βME solution required for the weight 
of the adrenal tissue (20µL/mg). The tubes were vortexed to ensure thorough 
mixing of the entire adrenal gland lysate. Six-hundred-µL aliquots of each 
lysate were placed into 2mL RNase-free Eppendorf tube and stored at -80°C.  
 
2.5ii: RNA, DNA and Protein Extraction 
 
RNA, DNA and protein were extracted from the lysate produced in section 
2.5i using a Qiagen AllPrep DNA/RNA/Protein Mini kit (Qiagen, Crawley, UK); 
all reagents mentioned are from this kit, unless otherwise stated. The 
procedure was carried out following the standard kit protocol with the 
addition of an on-column DNase digestion step.  
In brief, each 600µL aliquot of homogenised adrenal gland lysate was 
defrosted on ice before RNA, DNA and protein extraction. To maximise 
protein integrity, protease inhibitors were added: 1.5µL of Protease Inhibitor 
Cocktail, and 6µL of each Sigma Phosphatase Inhibitor Cocktail 2 and 3 
(Sigma-Aldrich, Dorset, UK) per sample. The phosphatase inhibitors were 
added to allow for later analysis of phosphorylation, which was not included 
in this study.  
 
RNA Extraction  
 
The lysate was then centrifuged at >16,000g for three minutes, and the 
supernatant was transferred to a Qiagen AllPrep DNA column placed in a 2mL 
collection tube. This was then centrifuged at >8000g for 30 seconds and the 
column stored at 4°C for later DNA purification. Four hundred and thirty-µL of 
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100% ethanol was added to the remaining flow-through, and 700µL of this 
solution was transferred to an RNeasy spin column, placed within a 2mL 
collection tube. This was then centrifuged at >8000g for 15 seconds and the 
flow-through stored at 4°C for later protein purification. This step was 
repeated to ensure all the initial lysate was processed. Three hundred and 
fifty-µL of wash Buffer RW1 was added to the RNeasy spin column and 
centrifuged. DNase I incubation mix (10µL DNase I stock solution and 70µL 
RDD buffer: RNase-Free DNase Set,  Sigma-Aldrich, Dorset, UK) was then 
added directly to the RNeasy column, and incubated at room temperature 
(20-30oC) for 15 minutes. Once incubation was complete, a further 350µL of 
wash buffer RW1, followed by two 500µL applications of buffer RPE, a mild 
wash buffer to remove traces of salt, were added to further wash the column, 
with centrifugation at >8000g for 15 seconds following each addition. Finally 
to ensure no wash buffers remained, the RNeasy column was added to a new, 
dry collecting tube followed by a final centrifugation (>16,000g for one 
minute). The RNeasy column was placed in a 1.5mL collection tube and 50µL 
RNase-free water was directly added to the spin column membrane, 
centrifuged (8000g for one minute) and the RNA-containing flow-through was 
stored at -80°C for later cDNA synthesis.  
 
DNA Extraction  
 
The AllPrep DNA column was removed from the fridge and 500µL of wash 
buffers  AW1 and AW2 were added successively to the column, with 
centrifugation at >8000g for 15 seconds after each addition, and the flow-
through discarded. One-hundred µL of elution buffer EB (preheated to 70°C) 
was added directly to the column membrane, and incubated at room 
temperature for two minutes, followed by a final centrifugation at >8000g for 
one minute into a new 1.5mL collecting tube. The DNA-containing flow-
through was stored at -80°C.  
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Protein Extraction  
 
Nine hundred-µL of buffer APP, a protein purification buffer which contains 
zinc chloride, was vigorously mixed with the previously stored flow-through 
from the RNeasy column and incubated at room temperature for 10 minutes, 
followed by 10 minutes of centrifugation at >16,000g. The supernatant was 
then decanted and 500µL of 70% ethanol was added to the protein pellet, 
ensuring that the pellet was floating within the ethanol. The protein pellet 
was then centrifuged for one minute at >16,000g, the ethanol removed and 
the pellet was left to dryat room temperature for a maximum of four minutes. 
After drying, 50µL of Modified Reswell Solution (MRS; 7M urea, 2M thiourea, 
4% (w/v) CHAPS, 0.3% (w/v) DTT) was added to enable protein solubilisation. 
The protein pellets were then stored on ice until full re-suspension had 
occurred, then stored at -80°C.   
 
2.5iii: Complementary DNA Synthesis 
 
RNA purity and concentrations were measured using a NanoDrop ® ND-1000 
spectrophotometer and Labtech International Ltd software (Ringerm, UK). A 
cDNA copy of the RNA was then generated by reverse transcription using a 
Transcriptor First Strand cDNA Synthesis Kit (Roche, Burgess Hill, UK) 
following kit procedure A using random hexamer primers. All reagents used 
were from the Transcriptor First Strand cDNA Synthesis Kit unless otherwise 
mentioned.  
Eleven-µL of each RNA sample (diluted to matching concentrations using PCR 
grade water (Roche Diagnostics Ltd, UK)) was added to PCR tubes. Nine-µL of 
master mix containing transcriptor RT reaction buffer, protector RNase 
inhibitor, deoxynucleotide mix, transcriptor reverse transcriptase and random 
hexamer primers was premixed in bulk (volumes following manufacturer’s 
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instructions) was also added. PCR tubes were centrifuged at <7000g for 15 
seconds, and incubated in a Techne TC-512 thermal block cycler (Keison 
Products, Exeter, UK) for 10 minutes at 25°C, 30 minutes at 55°C, five minutes 
at 85°C and maintained at 4°C. The resulting cDNA was stored at -80°C. The 
same reaction was completed for pooled cDNA samples from each treatment 
group replacing the transcriptor reverse transcriptase with PCR-grade water 
to produce RT-negative controls.  
 
2.5iv: Real-Time PCR 
 
The expression of gene cDNA was quantified by quantitative real-time PCR 
(qRT-PCR) using a Roche LightCycler ® 480 machine (Roche, Burgess Hill, UK). 
The target gene was quantified using gene-specific primers for the following 
target genes: CYP11A1, CYP17A1, 3βHSD, ER1, MC2R, CRHR1 and AGTR1. The 
reference housekeeping genes were YWHAZ, GAPDH and HPRT1 as per 
previously published work on the ovine sewage sludge model (Lea et al., 
2014a). The three reference genes and ER1 were detected using TaqMan® 
probes with a 5’-6’-carboxyfluoroscein (FAM) reporter and 3’-labelled 3’-6’-
carboxyl-N,N,N’,N’-tetramethtylrhodamine (TAMRA) quencher (Eurofins 
MWG Operon, London UK). All other genes were detected using Roche 
Universal Probe Library probes, 5’-labelled with FAM and 3’-labelled with a 
reporter (Roche Diagnostics Ltd., West Sussex, UK), designed using the Roche 
ProbeFinderTM software (http://lifescience.roche.com/ accessed on 15th and 
23rd of July and 18th August 2014). All primers and probes were designed from 
the respective Ovis aries gene sequences. Details of primers and probes are 
summarised in Table 4.  
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Gene NCBI Accession Primer / Probe Base Sequence 
MC2R NM_001009442.1 
Gene length: 1023bp 
Amplicon length: 64bp 
Forward 
Reverse 
 
Probe 
Roche probe  
CGTCCTGACGGTCCTCTG 
ATGGGAGAAGGTCACAATG
G 
CAGTGGCA 
#59 
CRHR1 NM_001009727.1 
Gene length: 1248bp 
Amplicon length: 62bp 
Forward 
Reverse 
 
Probe 
Roche probe 
GCCTGGGGTGTACACTGATT 
AATTGATCAGCAGGACCAAG
AT 
CCAGGGCC 
#81 
AGTR1 NM_001009744.1 
Gene ength: 2358bp 
Amplicon length: 71bp 
Forward 
Reverse 
 
Probe 
Roche probe  
CCACATTCTGCCATGTTTTG 
TTCATCCAGTTTCTGACATCA
GTT 
GATGCCCA 
#105 
3BHSD1  NM_001135932.1 
Gene length: 1122bp 
Amplicon length: 61bp 
Forward 
Reverse 
 
Probe 
Roche probe  
TGACCTCAATTACACTTTGAG
CA 
AAGGCTCATCCGGGAATC 
CTTCTGCC 
#29 
CYP11A1  NM_001093789.1 
Gene length: 1826bp 
Amplicon length: 60bp 
 
Forward 
Reverse 
Probe 
Roche probe  
CCACTGCTGAATCCAGTGTC 
CTGCTTGATGCGCTTGTG 
CAGCCTCC 
#75 
CYP17A1 NM_001009483.1 
Gene length: 1728bp 
Amplicon length: 60bp 
 
Forward 
Reverse 
Probe 
Roche probe  
CCACCCCACACAATTAGAGG 
CGGGGAGGAAGAAGGAAT 
CTTCTCCC 
#7 
ER1 Europhins 
Gene length: 5779bp 
Amplicon length: 66bp 
Forward 
Reverse 
Probe 
TTTCGAGGGTCACTACCAGT 
GTCAATTGCCTCATTGAACC 
CAGCTGGCCACCACTGGCTG
C 
YWHAZ Europhins 
Gene length: 738bp 
Amplicon length: 85bp 
Forward 
Reverse 
Probe 
GGAGCCCGTAGGTCATCTTG 
CTCGAGCCATCTGCTGTTTTT 
CAGCACCTTCCGTCTTTTGCT
CAATACTGGAGA 
GAPDH Europhins 
Gene length: 1285bp 
Amplicon length: 103bp 
Forward 
Reverse 
Probe 
ACTACCATGGAGAAGGCTG
G 
GGTTCACGCCCATCACA 
AGAGGGTCATCATCTCTGCA
CCTTCT 
HPRT1 Europhins 
Gene length:1405bp 
Amplicon length: 100bp 
Forward 
Reverse 
Probe 
GAACGGCTGGCTCGAG 
CCAACAGGTCGGCAAAG 
AATGTGATGGCCACCCATCT
CCT 
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Table 4: Primer and Probe Sequences for quantitive Real-Time PCR 
 
2.5v: Optimisation   
 
Primer optimisation  
 
Primer optimisation to maximise the performance of qRT-PCR was completed 
by running cycles with varying concentrations of the forward and reverse 
primers using a 1-in-10 dilution of pooled cDNA for each gene. This involved a 
cocktail of 10µL of ProbeMaster master-mix (Roche Diagnostics Ltd., Burgess 
Hill, UK), varying volumes of forward and reverse primers and probes (see 
Tables 5 and 6), cDNA and PCR-grade water to make up to a final volume of 
20µL. For TaqMan® Probes, 0.7µL of probe was required per reaction, 
whereas Roche Probes required 0.1µL of probe per reaction. Each 
optimisation was performed in duplicate. qRT-PCR 96-well plates were then 
centrifuged for two minutes at 1000g, before undergoing an automated 
Roche LightCycler® 480 qRT-PCR reaction following the parameters given in 
Table 7.  
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  Forward : Reverse Primer Ratio 
 Primer conc 
(pmol/µL) 
Probe conc 
(pmol/µL) 
300F/300R 
(µL) 
300F/900R 
(µL) 
900F/300R 
(µL) 
900F/900R 
(µL) 
Master Mix   10.0 10.0 10.0 10.0 
Forward Primer 5  1.2 1.2 3.6 3.6 
Reverse Primer 5  1.2 3.6 1.2 3.6 
Probe  5 0.7 0.7 0.7 0.7 
PCR-grade H2O   4.9 2.5 2.5 0.1 
cDNA   2.0 2.0 2.0 2.0 
Table 5: Roche 20µL System Real Time PCR Optimisation for TaqMan® Probes 
 
  Forward : Reverse Primer Ratio 
 Primer conc 
(pmol/µL) 
Probe conc 
(pmol/µL) 
300F/300R 
(µL) 
300F/900R 
(µL) 
900F/300R 
(µL) 
900F/900R 
(µL) 
Master Mix   10.0 10.0 10.0 10.0 
Forward Primer 5  1.2 1.2 3.6 3.6 
Reverse Primer 5  1.2 3.6 1.2 3.6 
Probe  5 0.1 0.1 0.1 0.1 
PCR-grade H2O   5.5 3.1 3.1 0.7 
cDNA   2.0 2.0 2.0 2.0 
Table 6: Roche 20µL System Real Time PCR Optimisation for Roche Universal Probe Library Probes 
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Temperature (°C) Time Number of 
Cycles 
Phase 
95 10 Minutes 1 Pre-incubation 
96 10 Seconds 45  
Amplification 60 30 Seconds 45 
72 1 Second 45 
40 30 Seconds 1 Cooling 
Table 7:  Real-time PCR Run cycle 
 
Standard Curve Protocol  
 
Two-µL of each sample was combined to make a pooled cDNA stock solution. 
This was diluted in a 1 in 5 serial dilution: Neat, 1:5, 1:25, 1:125, 1:625 and 
1:3125. A PCR run was completed for each gene at optimised primer 
concentrations, along with qPCR grade water as a negative control. The PCR 
was then completed following the protocol in Table 7, after a two-minute 
centrifugation at 2000rpm. All standard curves were repeated four times, and 
a mean of the efficiencies was used for later relative gene expression analysis.  
 
Gel electrophoresis 
 
As the amplicons were too small for sequencing (apart from YWHAZ, which 
was successfully and correctly sequenced by SourceBioScience, Nottingham, 
UK), electrophoresis was used to determine amplicon size. Ethidium bromide 
(7.5µL) fluorescence dye was added to a 1.5% agar gel, and PCR product was 
mixed with loading buffer and run with a 100-1000 base pair ladder at 100V 
for two hours in 1% Tris-Acetate-EDTA buffer. Images were taken using 
IQuant Capture 3000 (GE Health Care, Little Chafont, UK).  
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2.5vi: PCR Runs 
 
All runs used the master mix cocktail (Tables 5 and 6) using 2µL of each 
sample cDNA, following the run protocol in Table 7 using a Roche LightCycler® 
480. A pooled cDNA sample was run under the same conditions on each plate 
for each gene as a calibrator to control for plate-to-plate variation, as well as 
PCR grade water as a negative control (no template control). All samples were 
measured in duplicate. As for optimisation and standard curve protocols, each 
plate was sealed and centrifuged for two minutes at 2000rpm before running 
the PCR protocol (Table 7). RT-negative controls were run under the same 
conditions for each gene to determine the contribution of contaminating 
genomic DNA to the overall target sample.  
Gene expression data were analysed relative to a stable reference gene using 
the Roche Applied Science E-method, using Roche software (Roche 
Diagnostics Ltd., Burgess Hill, UK). This normalises the genes of interest to the 
most stable reference gene, normalising sample-to-sample differences, and 
an inter-assay calibrator to normalise for run-to-run differences, using 
efficiencies produced by the standard curves.  
 
2.5vii: geNorm Method 
 
Gene expression levels need to be normalised using stable internal control 
(housekeeping) genes (Vandesompele et al., 2002), and a housekeeping gene 
is required to measure expression accurately. geNorm is an algorithm which 
determines the most stable housekeeping reference gene from a selection of 
tested reference gene Ct values. Ct values from three housekeeping genes 
(HPRT1, GAPDH and YWHAZ) from 53 different cDNA samples (samples from 
each treatment group and control) were entered into the geNorm excel 
macro. This macro determined variation of these housekeeping genes within 
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the different samples. The best housekeeping gene has the smallest variation 
in Ct value within the 53 samples across the treatment groups. In this case, 
YWHAZ was the most stable gene, and was therefore selected as the 
housekeeper gene. geNorm provides an M value (average expression stability 
value, which needs to be less than 1). The M value for YWHAZ was 0.76.  
 
 
2.6: Statistical Analysis 
 
Statistical analysis was completed using the GenStat® statistical software (VSN 
International Ltd, Hemel Hempstead, UK). Since data were generated from an 
unbalanced two-way design, they were analysed by the mixed linear 
restricted maximum likelihood (REML) algorithm in which treatment and 
gender formed the fixed effects, adrenal weights and fetal weights were 
covariates. The ewe formed the random effect and the model recognised the 
ewe as the replicated variable. 
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3. Results 
 
3.1: Fetal Infomation 
 
Fetal adrenals were collected from 112 ovine fetuses from 58 ewes allocated 
to each of the five treatment groups described in materials and methods and 
listed in Table 8. Significantly more male than female fetuses were included in 
this study (p=0.05, t-test).  
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Treatment 
Group 
No. 
Ewes 
No. 
Fetuses 
Gender 
    Male          Female 
Parity 
   Singles        Twins         Triplets 
Left adrenal 
(mg) 
SEM Right adrenal 
(mg) 
SEM 
Control 14 27 18 9 1 26 0 298.23 12.05 327.69 15.23 
Continuous 11 20 12 8 4 10 6 291.1 18.39 270.51 10.01 
Early 10 18 9 9 2 16 0 256.28 14.02 238.84 10.12 
Mid 11 23 12 11 1 16 6 270.7 10.47 292.03 13.42 
Late 12 24 14 10 2 16 6 240.14 10.01 258.62 11.92 
TOTAL 58 112 65 47 10 84 18 - - - - 
Table 8: Effects of sewage sludge chemicals on gender, litter size and fetal adrenal weight. Values represent mean ± SEM of average raw adrenal 
weights for the left and right adrenal glands. The left adrenal gland was snap frozen in liquid nitrogen, and then stored at -80°C for RNA, DNA 
and protein extraction, and further molecular analyses. The right adrenal was fixed in Bouin’s solution, and then stored in 70% ethanol at 4°C for 
tissue processing and morphological analyses. 
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3.2: Histology Studies 
 
3.2i: Adrenal Sample Set 
 
Out of the 112 adrenals that were fixed in Bouin’s solution and stored in 70% 
ethanol, only 50 could be processed for morphological analyses. A number of 
the stored adrenals had dried out due to the length of time between tissue 
harvesting and further processing and this was beyond the control of the 
study. Despite rehydrating all affected samples, it was not possible to obtain 
satisfactory 5µm sections from them all. Table 9 below shows the number of 
fetuses that were satisfactorily sectioned for morphological analyses across 
the treatment groups. As with the complete sample set, there were more 
male than female fetuses in this sample set (p=0.025, t-test). 
 
Treatment 
Group 
No. 
Ewes 
No.  
fetuses  
Gender 
Male Female  
Parity 
Singles        Twins            Triplets  
Control 7 9 5 4 1 8 0 
Continuous 8 8 6 2 3 4 1 
Early 7 8 4 4 2 5 1 
Mid 9 13 9 4 1 8 4 
Late* 7 12 7 4 1 8 2 
Total 38 50 31 18 8 33 8 
Table 9: Fetal gender and total number of adrenals processed for 
immunohistochemical analysis for each treatment group. * Gender and parity 
of one fetus is unknown in this group. 
 
3.2ii: Histological Appearance  
 
Fetal adrenals were sectioned and stained with haematoxylin and eosin. 
Figure 14 below shows a representative section of a fetal adrenal gland (5µm) 
at 100x magnification. The layers of the cortex, the chromaffin cells of the 
medulla all encased within the fibrous capsule can clearly be seen. Figure 15 
 
 
76 
 
shows high power images of each region of the day 140 ovine fetal adrenal 
gland. Initial gross histological examination of these fetal adrenal glands 
showed no obvious differences between the different treatment groups.  
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. 
  
Figure 14: Morphological characterisation of a day 140 ovine fetal 
adrenal gland from the control group. ZG: zona glomerulosa: irregular 
ovoid clusters of cells surrounded by trabeculae. Continuous with 
fibrocollagenous capsule (C). Large number of capillaries. Large round 
nuclei and little cytoplasm. Produce mineralocorticoids. ZF: zona 
fasciculata: Narrow columns of cells with large capillaries. Cells 
contain pale staining cytoplasm (lipid droplets). Secrete 
glucocorticoids. DZR: developing zona reticularis: will develop post-
natally to be an irregular network of branching clusters of small 
granular cells with darker staining cytoplasm, which secrete 
androgens and glucocorticoids. Not found in the fetal adrenal gland. 
M: medulla: clusters of granular, faintly basophilic chromaffin cells, 
supported by stroma, contains ample capillaries. The granules contain 
catecholamines: epinephrine and nor-epinephrine. Magnification = 
100x. 
C 
ZF 
DZR 
M 
ZG 
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Figure X: Ovine fetal 
adrenal cortex, Zona 
reticularis (ZR) and 
adrenal medulla (M) 
from a 140 day old 
fetus (0-140C). H&E, 
20x. 
 
Figure X: Ovine fetal 
adrenal cortex, Zona 
reticularis (ZR) and 
adrenal medulla (M) 
from a 140 day old 
fetus (0-140C). H&E, 
20x. 
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Figure 15: Histological features of the day 140 ovine fetal adrenal gland from 
control group. A: Adrenal medulla. Predominantly chromaffin cells are present 
(*) with a capillary within the supporting stroma (arrow). B: Adrenal cortex: 
zona fascicularta (ZF) and adrenal medulla (M). C: Adrenal cortex:  ovoid 
clusters of the zona glomerulosa (ZG), adrenal capsule (Cap) and fibrous 
trabeculae (arrow). D: Adrenal cortex: zona fascicularta. All sections were 
stained with haematoxylin and eosin.  
 
3.3: Immunolocalisation of CYP17A1 and AGTR1 
 
Sections (5µm) were incubated with one of two specific anti-ovine 
steroidogenic antibodies, specifically the enzyme CYP17A1 or the receptor 
AGTR1.  
 
Figure 16 shows typical stained sections at 50x and 200x magnification for 
both CYP17A1 and AGTR1. The intensity of the staining for CYP17A1 varies 
throughout the cortex, with the outer most layer, the zona glomerulosa, 
staining relatively less than the rest of the developing cortex (mainly zona 
fasciulata, as the zona reticularis is not fully developed until after birth 
(Tangalakis et al., 1992)). The central medulla and capsule show minimal 
staining by the anti-CYP17A1 antibody, however, some steroidogenic cells 
were stained around the central medullary vein. Anti-AGTR1 also 
predominantly stains the adrenal cortex, including the outer-most zone, the 
zona glomerulosa and the zona fasciculata; however, some specific staining 
can also be seen in the medulla and around the central medullary vein. No 
staining was observed on negative isotype Rabbit IgG controls. 
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Figure 16: Localisation of CYP17A1 and AGTR1 protein in day 140 ovine fetal 
adrenal: A, C: CYP17A1 immunostaining of the adrenal cortex at low (A) and 
high (C) magnification. C shows the cortical-medullary boundary with some 
positive staining in the medulla. E, G: AGTR1 immunostaining at low (E) and 
high (G) magnification showing dark staining within the cortex and more 
limited staining in the medulla. Low and high magnification = 50x and 200x 
respectively. Inserts (B, D, F and H) are the corresponding negative controls 
incubated with non-specific Rabbit IgG. All are counterstained with 
haematoxylin.  
 
3.3i: Cortical Thickness  
 
Since CYP17A1 and AGTR1 antigen were primarily localised to the developing 
cortex (Figure 16), CYP17A1 primarily being found in the zona fasciculata, and 
AGTR1 being found in the zona glomerulosa and zona fasciculata, the 
thickness of the respective cortical regions were measured. A mean of eight 
measurements were taken at regular intervals across the whole adrenal 
section, for each sample (see materials and methods). Figure 17A and B show 
the scatter of the measurements for CYP17A1 and AGTR1 respectively. There 
was a significant treatment effect on cortical thickness as measured by 
CYP17A1 (p=0.037) and AGTR1 (p=0.031) (REML). This is further illustrated in 
Figure 18A and B showing the predicted means for CYP17A1 and AGTR1 
generated by REML analysis. With both markers, the late gestation exposure 
groups showed the greatest difference from controls and had the lowest 
cortical thickness (Figure 17A, B, Figure 18A, B).  AGTR1 also exhibited a 
significant gender effect (p= 0.027) and treatment by gender interaction 
(p=0.048) and Figure 18D illustrates that the greatest effects were seen in the 
females (REML).  There was a suggestion of a treatment by gender interaction 
for CYP17A1 (p=0.081) and Figure 18C suggests that the greatest variation is 
between the females in the control group and the females in the mid and late 
gestation treatment groups. 
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3.3ii: Percentage Area Stained 
 
No significant treatment effects were observed on percentage cellular area 
stained for CYP17A1 or AGTR1 (Figure 17C and D respectively). Percentage 
area stained by AGTR1 was consistently greater than that measured by 
CYP17A1 (Figure 17E). This is likely due to the staining observed in the zona 
glomerulosa and in the medulla. Despite the lack of a treatment effect, lowest 
levels were observed in the late gestation treatment group for both CYP17A1 
and AGTR1. A significant CYP17A1 treatment by gender effect was observed 
(p=0.04, REML).  Wide variation in staining was observed within the different 
treatment groups and this was particularly evident for AGTR1 (Figure 17D).  
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Figure 17: Effects of sewage 
sludge exposure on fetal 
adrenal gland staining for 
CYP17A1 and AGTR1. Scatter 
graphs show cortical thickness 
and percentage of entire 
adrenal gland stained for 
CYP17A1 (A, C) and AGTR1 (B, 
D), A combined scatter graph 
of C and D can be seen in E, 
indicating the difference in 
percentage area stained 
between the two antibodies 
(red=CYP17A1, back = AGTR1). 
Horizontal lines indicate the 
mean values. n=50 [Control 
(9), Continuous (8), Early (8), 
Mid (13), Late (12)]. 
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Figure 18: Effects of maternal sewage sludge exposure on day 140 fetal adrenal 
gland staining for CYP17A1 and AGTR1. Histograms showing predicted values 
for treatment interactions (A, B) and treatment by gender interactions (C, D) 
for cortical thickness staining for CYP17A1 (A, C) and AGTR1 (B, D). Line 
indicates SED.  
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3.4: Real-time PCR Optimisation 
 
A number of steps were taken to optimise the real time PCR method in these 
experiments and to minimise non-specific effects, including investigating the 
presence of contaminating genomic DNA, optimising the concentration of the 
primers, checking the size (base pairs) of the PCR products as an indication of 
reaction specificity, and determination of the reaction efficiency.  
 
3.4i: RT-Negative Controls 
 
A reverse-transcriptase negative (RT-negative) control is a reaction containing 
all the reverse transcriptase PCR (RT-PCR) reagents but omitting the reverse 
transcriptase enzyme. Any subsequent amplification can therefore only be 
attributed to contaminating genomic DNA. During the extraction of RNA, a 
DNA digestion step using DNase was included to remove contaminating 
genomic DNA. However, since it is impossible to remove all contaminating 
genomic DNA, it is paramount to determine the residual level of 
contaminating genomic DNA within the samples. Figure 19 shows an example 
of RT-negative control results for 3βHSD using pooled cDNA from each 
exposure group. Amplification of cDNA occurring after 19 cycles represents 
3βHSD whereas the amplification curves arising after 31 cycles represent 
contaminating genomic DNA. Figure 14 therefore shows that the Ct values for 
the contaminating genomic DNA are far higher than the Ct values of the 
cDNA. Since more cycles are required to amplify the genomic DNA, it is 
present at much lower levels than the cDNA of interest. An RT-negative 
control Ct value which is 10 cycles higher than that of the cDNA indicates that 
the contaminating genomic DNA is contributing 0.1% to the target signal and 
is therefore deemed negligible (Biosystems, 2015), and a difference of 6 
cycles is deemed as acceptable (Dr M Rae, personal communication).  
Comparisons of the cDNA and the RT-negative controls (contaminating 
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genomic DNA) for all target genes (target and reference) are shown in Table 
10 below.  
 
Figure 19: A representative graph for the target gene 3βHSD showing 
florescence of cDNA (left amplification curves) and contaminating genomic 
DNA (RT-negative controls; right amplification curves) for pooled treatment 
group samples.  
 
Gene and Tx Group RT Negative cDNA Difference 
AGTR1    
Control 34.03840373 24.95536873 9.083035003 
Continuous 34.555751 25.59812506 8.957625935 
Early 34.66113711 25.1755701 9.485567005 
Mid 34.82585518 24.08320749 10.74264769 
Late 35.16197366 25.20807654 9.953897121 
    
MC2R    
Control 33.81995755 25.67229426 8.147663289 
Continuous 33.25877879 25.88866423 7.370114563 
Early 34.89240839 25.70964675 9.182761645 
Mid 34.62689545 25.22536167 9.401533774 
Late 33.67649656 26.02063952 7.655857041 
    
3βHSD    
Control 33.22814964 19.90563104 13.3225186 
Continuous 33.64775655 20.56508657 13.08266997 
Early 33.28737794 20.24032829 13.04704965 
Mid 34.98590843 20.16419048 14.82171795 
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Late 33.49055115 20.54528345 12.9452677 
    
CYP11A1    
Control 32.41179171 21.24861115 11.16318056 
Continuous 32.87753198 21.93883129 10.93870069 
Early 32.65564617 21.52271809 11.13292808 
Mid 33.4741708 21.69021753 11.78395328 
Late 33.18600191 22.4918259 10.69417601 
    
CYP17A1    
Control 34.50495011 24.08810226 10.41684785 
Continuous 34.19932009 24.64207021 9.557249884 
Early 34.16133511 23.51026338 10.65107173 
Mid 35.3485045 24.88495528 10.46354922 
Late 34.8788779 25.42242003 9.456457873 
    
YWHAZ    
Control 33.15157841 25.72101258 7.430565831 
Continuous 32.98924913 26.08819492 6.901054207 
Early 32.79128326 25.64137056 7.149912698 
Mid 33.9268947 25.87597706 8.050917638 
Late 33.32609568 25.80540707 7.520688609 
    
CRHR    
Control 33.05441135 30.60428069 2.450130653 
Continuous 32.327317 30.75694277 1.570374226 
Early 32.20979277 30.58628746 1.62350531 
Mid 33.8711995 30.07017954 3.80101996 
Late 32.82194382 31.01364232 1.808301497 
Table 10:  Ct values for target genes and residual genomic DNA (RT-negative 
controls).   
 
Table 10 illustrates that the amplification of contaminating genomic DNA is 
negligible for all genes other than CRHR1. Consequently, data from this gene 
were removed from further analysis.  
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3.4ii: Primer Optimisation 
 
To obtain the most efficient amplification of target RNA, the primers used 
were tested over a range of concentrations. The concentration of forward and 
reverse primers that produced the most efficient amplification was then 
selected for use. Table 11 below shows the volumes of each reagent used in 
the optimised 20µL PCR reaction.  
 
Genes  AGTR1, MC2R 
and 3βHSD 
CYP17A1 and 
CYP11A1 
ER1 and YWHAZ 
Forward (F) and reverse 
(R) Primer Concentration 
(nM) 
F: 300nM 
R: 900nM 
F: 900nM 
R: 900nM 
F: 300nM 
R: 900nM 
Master mix 10.00 10.00 10.00 
Forward Primer 
(pmol/µL) 
1.20 3.60 1.20 
Reverse Primer 
(pmol/µL) 
3.60 3.60 3.60 
Probe (pmol/µL) 0.10 0.10 0.70 
cDNA 2.00 2.00 2.00 
PCR-grade H2O 3.10 0.70 2.50 
    
Total Volume 20.00(µL) 20.00(µL) 20.00(µL) 
Table 11:  Optimised concentrations of forward and reverse primers for target 
and reference genes 
 
Table 11 shows the optimised concentrations for each forward and reverse 
primer for all target and reference genes. The concentrations of reverse and 
forward primers used in the PCR reactions are highlighted in the table.  
 
3.4iii: Gel Electrophoresis  
 
In order to confirm that the size (base pair) of the PCR products (amplicons) 
were as predicted (an indication of reaction specificity), the amplification 
products were examined on agarose gel electrophoresis and compared to a 
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standard DNA ladder of 100-1000 base pairs. A representative electrophoresis 
gel of the PCR products, stained with ethidium bromide and viewed under 
ultra-violet light, is shown in Figure 20. The bands are indicative of the size of 
the amplicon produced in each PCR cycle. Only a single bright band is evident 
for each gene approximating to the anticipated amplicon size. This indicates 
that the gene of interest has been amplified rather than detectable amounts 
of higher molecular weight genomic DNA. The predicted amplicon size for 
each gene is shown in Table 12.   
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Electrophoresis of fetal adrenal gland nucleic acid amplified using 
the designed primers. 1: 1kb Ladder, 2: CYP17A1, 3: CYP11A1, 4: GAPDH, 5: 
MC2R, 6: 3βHSD, 7: AGTR1. Bands represent target genes and one 
housekeeping gene (GAPDH) (lane 4), compared with a 100-1000 base-pair 
ladder (1). All bands (except GAPDH) are less than 100 base pairs. 
  
 
 
Page | 90 
 
 
 
 
 
 
Table 12: Amplicon size (in base pairs) of genes of interest and one reference 
gene (GAPDH). 
 
3.4iv: PCR Efficacy 
 
To determine the efficiency of the PCR reactions, a standard curve was 
completed for each target and reference gene using a range of dilutions of a 
pooled cDNA sample. A reaction which is 100% efficient (cDNA of interest 
doubles in each cycle), has an amplification factor of 2. The efficiency is 
calculated from the slope of a semi-logarithmic plot (Figure 21B) derived from 
the Ct values (Figure 21A).  
  
Gene of interest Amplicon size (base pairs) 
CYP17A1 60 
CYP11A1 60 
GAPDH 103 
MC2R 64 
3βHSD 61 
AGTR1 71 
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Figure 21: GAPDH amplification graph at different cDNA concentrations (A) and 
an example of a standard curve calculated from the crossing points and log 
concentration values (B).  
 
The standard curves were repeated four times. The mean of the amplification 
numbers obtained are shown in Table 13. 
  
A 
B 
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Gene Amplification Number 
AGTR1 1.82 
MC2R 1.98 
CYP11A1 2.05 
CYP17A1 1.91 
3βHSD 2.01 
ER1 1.95 
YWHAZ 1.95 
GAPDH 1.90 
HPRT1 1.93 
Table 13: Mean amplification number for each gene. 
 
3.4v: Optimal Reference Gene Selection 
 
Table 14 below shows the M values for the three tested reference genes 
(YWHAZ, GAPDH and HPRT1) from the geNorm algorithm. In tissue samples, 
reference genes are typically more variable than when they are in samples 
from a single cell type, and a value of M <1.0 is acceptable (Dahene, 2013). As 
can be seen, YWHAZ has the lowest M value (0.76) and is therefore the most 
stable reference gene.  
 
Reference Gene M-Value 
YWHAZ 0.760 
GAPDH 0.905 
HPRT1 1.025 
Table  14: Reference gene M-values 
 
 
3.5:  Real-Time PCR Results  
 
To investigate the relative gene expression for the target genes across 
treatment groups, qRT-PCR was performed on samples from 105 fetuses. 
Following optimisation described in Section 3.1 above, and selection of the 
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most suitable reference gene (YWHAZ), qRT-PCR was carried out on all 
samples. Target genes amplified were AGTR1, MC2R, CYP17A1, CYP11A1, 
3βHSD and ER1 (unfortunately, due to availability of ER1 primers, RT-negative 
controls and electrophoresis was not completed).  In the control and each of 
the treatment groups, a proportion of fetal adrenals did not express CYP17A1. 
The largest proportion of CYP17A1 negative samples was found in the late 
gestation exposure group (54%) compared to 23% of the controls (P<0.05: 
Fishers Exact Test). 
 
3.5i: Relative Gene Expression 
 
The expression of all target genes was expressed relative to the reference 
gene YWHAZ using Roche software (see materials and methods). Initially, the 
residuals of the data were examined to ensure normal distribution (Figure 
22).  
 
 
Figure 22: Example of testing for normality of real time PCR data. Residuals are 
shown for AGTR1 showing a positive skew in non-transformed data and a 
normal distribution following log transformation. Residual plots were 
generated by Genstat software (16th edition).  
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Examination of the residuals revealed abnormally distributed data for AGTR1; 
therefore data was log-transformed for analysis. All other data were normally 
distributed; and therefore original data sets were used.  
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Figure 23: Effects of maternal sewage sludge exposure on fetal adrenal gland 
expression of target genes in day 140 fetal adrenals. Scatter graphs show gene 
expression data for AGTR1 (A), MC2R (B) and ER1 (C) and steroidogenic 
enzymes CYP17A1 (D), CYP11A1 (E) and 3βHSD (F). All genes are expressed 
relative to the YWHAZ housekeeping gene. Horizontal lines indicate means. 
n=105 [Control (22), Continuous (18), Early (18), Mid (23), Late (24)]. 
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Due to the unbalanced experimental design, REML was used for statistical 
analysis of each of the target genes. No significant treatment effect was 
observed on AGTR1 (Figure 23A).  However, there was a near significant effect 
of gender (p=0.053) but no treatment by gender interaction. No significant 
interaction between relative expression of MC2R and treatment, or any of the 
other covariates (adrenal size, fetal size) was observed (Figure 23B). In 
contrast, a significant treatment effect was observed on the expression of ER1 
(p=0.042: Figure 23C). Relative to the control group, the lowest levels of ER1 
expression were observed in the mid and late gestation treatment groups 
(Figure 23C: raw data; Figure 24A: predicted means). No significant treatment 
effect was observed on the expression of CYP17A1 (Figure 23D). However, a 
significant treatment by gender interaction was observed (p=0.032) and figure 
24B indicates that this difference reflects measurements in the control and 
late gestation group with the females expressing significantly less CYP17A1. 
The expression of CYP17A1 also varied significantly with fetal weight (p=0.04: 
data not shown). There was no significant treatment effect on CYP11A1 or 
3βHSD (Figure 23E,F) however there was a suggestion of a significant 
treatment by gender interaction for 3βHSD (p=0.067). Male fetuses within the 
continuous treatment group appear to express less 3βHSD gene than their 
female counterparts (Figure 24C). 
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Figure 24: Effects of maternal sewage sludge exposure on fetal adrenal gland 
expression of target genes in day 140 fetal adrenals.  Histograms show 
predicted gene expression levels from REML analysis showing a significant 
treatment effect on ER1 (A) and significant treatment by gender interactions 
for CYP17A1 (B) and 3βHSD (C).  Error bars indicate SED.  
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4. Discussion 
 
Many studies have investigated the effects of man-made environmental 
chemicals on various aspects of the endocrine system, particularly the 
reproductive system (hypothalamic pituitary gonadal (HPG) axis) and the 
thyroid hormones. However, the hypothalamic pituitary adrenal  (HPA) axis 
and the adrenal gland have been rather neglected in this respect (Harvey et 
al., 2007). The adrenal gland is highly vascularised, and as many EDCs are 
lipophilic they are likely to accumulate within the cholesterol rich adrenal 
cortex (Harvey, 2014). In addition, the high concentration of CYP 
steroidogenic enzymes within the adrenal cortex have the potential not only 
to be the target of EDCs, but also have the ability to enzymatically convert the 
EDCs into possibly toxic metabolites and free radicals (Hinson and Raven, 
2006). Although there have been a number of approaches to investigating the 
endocrine effects of EDCs, most have involved the administration of, or 
exposure to, a single defined EDC and at higher than environmentally relevant 
concentrations. However, in reality, the environment is polluted by a complex 
mixture of EDCs; it has been estimated that there are approaching 10,000 
chemical entities implicated, including plasticisers, flame retardants, 
pesticides and pharmaceutical drug residues, each with the potential to 
interfere with the endocrine system (EPA, 2014). Furthermore, there are likely 
to be numerous interactions, both chemical and biological, between these 
compounds, resulting in the possibility of both enhancing and inhibiting their 
pathophysiological actions (Rhind et al., 2010a). 
The aim of this project was to use an established sheep model of real-life 
human exposure to a mixture of environmental chemicals to determine the 
effects of maternal EDC exposure on the developing fetal adrenal gland at 
different windows of gestation. For the first time, it has been shown that the 
ovine fetal adrenal gland is sensitive to in utero exposure of an 
environmentally relevant cocktail of endocrine disrupting compounds at 
environmentally relevant concentrations. Furthermore, the results show that 
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the ovine fetal adrenal gland is more sensitive to a transient 80-day window 
of exposure compared to continuous exposure throughout gestation. This 
observation was facilitated by the unique study design, which allowed the 
effects of exposure during early, mid and late gestation to be determined. 
Data presented indicate that fetal adrenal glands are most sensitive to in 
utero exposure to EDCs within sewage sludge fertiliser during the mid and 
late gestation periods. This was manifested by reduced ER1 mRNA as well as 
reduced levels of the steroidogenic enzyme CYP17A1 and the angiotensin-II 
receptor 1, AGTR1 protein, as measured by thickness of staining within the 
cortex in fetal adrenals derived from these two exposure periods. 
Interestingly, with respect to CYP17A1 and AGTR1, the females were more 
affected than the males and there was no overall treatment effect at the gene 
expression level. Moreover, a treatment by gender interaction did not reflect 
differences in the mid and late gestation groups. The difference between 
changes in the adrenal gene expression (tanscriptome) and protein 
expression (proteome) is consistent with previous findings, and likely reflects 
additional post-translational processes (Klopfleisch and Gruber, 2012).  
There are HPA gender differences which could result in this increased female 
sensitivity. In a cell-based ovine study, females were found to secrete more 
cortisol than their male counterpart in response to ACTH stimulation. 
However, basal cortisol production was found to be highest in adrenal 
cultures from intact male sheep (Canny et al., 1999) although this was an in 
vitro cell based study, and therefore had limitations. More importantly, in an 
in vivo ovine study across breeding and non-breeding seasons, again females 
showed significantly higher plasma cortisol levels post ACTH stimulation than 
their male counterparts (van Lier et al., 2003a). In addition to female sheep 
secreting more cortisol than their male counterparts, gonadectomy has been 
shown to reduce this difference, confirming the gonadal hormone roles in 
HPA activation (van Lier et al., 2003a, van Lier et al., 2003b).   
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4.1: Ovine Sewage Sludge Models 
 
There has been limited research completed on the effects of EDCs on the 
intact adrenal gland. Instead, much work has been conducted on cell lines 
including human adrenocortical H296R cells (Ohlsson et al., 2010). Even more 
specifically, the effects of EDCs have been studied using isolated 
steroidogenic enzymes (purified bovine adrenal 3beta-hydroxysteroid 
dehydrogenase) (Wong and Keung, 1999). Such in vitro approaches obviously 
do not reflect the complexities of the whole organism. Indeed, it is important 
not only to take into account the whole of the HPA axis but all other complex 
physiological interactions to paint a realistic picture of EDC exposure at the 
entire organism level. Domestic sheep are ideal for use as human models of 
fetal development (McMillen and Robinson, 2005), are exceptional models to 
study the fetal origins of adult disease (Padmanabhan and Veiga-Lopez, 2014), 
and are recognised as a relevant human model of HPA toxicity, and therefore 
EDC exposure (Zimmer et al., 2013).  
Previous work on the ovine sewage sludge model described in this study has 
shown that maternal tissue EDC levels are not generally affected by 
environmental EDC exposure; there was no difference in hepatic 
concentrations of specific EDCs in adult sheep comparing treated and control 
animals (Rhind et al., 2010b). However, fetuses of dams exposed to sewage 
treated pastures during pregnancy had significantly higher hepatic 
concentrations of EDCs (Rhind et al., 2010b) suggesting these chemicals 
accumulate in the fetus and that measuring maternal EDC tissue burden 
cannot predict fetal tissue levels. In addition, the ovine sewage sludge model 
has been used to demonstrate that low concentrations and complex mixtures 
of environmental EDCs impair fetal ovarian development (Fowler et al., 2008), 
fetal testis development, as shown by a reduction in gonocyte, Leydig and 
Sertoli cell numbers, and a reduced testicular weight (Paul et al., 2005), fetal 
thyroid development (Hombach-Klonisch et al., 2013) and fetal hypothalamic-
pituitary axis development (Bellingham et al., 2010). Buckley and colleagues 
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showed that in utero exposure to sewage sludge before and after conception 
resulted in significantly reduced fetal adrenal subcapsular vasculisation, and 
separation of the adrenal cortex and medulla was significantly delayed in 
treated groups compared to controls. Fetal adrenal development was 
therefore delayed and the transcriptional regulation of adrenal proteins were 
negatively impacted (Buckley, 2012). Data presented here on ER1, CYP17A1 
and AGTR1 provide further evidence for an EDC induced perturbation on the 
fetal adrenal.  
A key observation in the current study is that transient periods of maternal 
exposure have a greater effect on fetal development than continual exposure 
throughout the entirety of gestation, particularly in the mid and late gestation 
treatment groups. This is not without precedent since transient effects of 
maternal EDC exposure were also demonstrated by Bellingham and 
colleagues. These authors found that fetuses exposed for transient periods 
(EDC exposure before or after conception) had reduced primordial follicles 
compared to continually exposed treatment groups (EDC exposure before and 
after conception). In addition, there was a greater number of gene transcript 
changes in the transient treatment groups compared with continual exposure 
groups, confirming transient maternal exposure is more detrimental to fetal 
development than continual exposure. This also highlights the susceptibility 
of the fetus to maternal exposure of EDCs before conception (Bellingham et 
al., 2013). Fetal development is therefore more sensitive to changing 
exposure than continual exposure.   In utero exposure, followed by pre-
weaning exposure via maternal milk followed by direct post-weaning 
exposure, caused major spermatogenic abnormalities in a subset of adult 
male sheep, confirming that EDC exposure in the developmental period prior 
to puberty is able to cause adult male disorders (Bellingham et al., 2012).  
In the current study, the mid and late gestation treatment groups showed 
significant reductions in endocrine receptors (ER1 mRNA, AGTR1 protein) and 
the CYP17A1 steroidogenic enzyme protein within the fetal adrenal glands. 
Interestingly, the current findings are in agreement with results from the fetal 
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ovaries from the same study, which showed increased morphological atretic 
follicles and oocytes in the same transitory periods (mid and late gestation 
treatment groups) compared with controls (Lea et al., 2014a)(Lea et al., in 
preparation). Further evidence for a greater impact of a transient period of 
exposure compared to continuous exposure has come from unpublished 
studies of the same fetuses from the same mid and late gestation treatment 
groups. These fetuses were significantly smaller and had significantly reduced 
anogenital distances compared to the early and continuous gestation 
treatment groups and the controls (Lea et al., in preparation). Fetuses within 
this study also had significantly higher tissue concentrations of EDCs; this 
varies across different studies, suggesting an independent control of EDC 
concentrations (Rhind et al., 2010b).  
 
4.2: Steroidogenic Enzymes  
 
Toxicological studies have shown that steroidogenic enzyme gene targets are 
sensitive to pharmacological concentrations of specific EDCs. The data in this 
study have now shown that fetal adrenal glands are also sensitive to 
environmental concentrations and mixtures of EDCs. These anthropogenic 
chemicals have the capacity to interact within complex pathways, and 
therefore may exert their effects on several parts of the common 
steroidogenic pathway (Nielsen et al., 2012), which can precipitate 
dysfunction at lower exposure concentrations (Harvey, 2014). 
The rate-limiting step for the production of steroidogenic hormones is the 
carriage of cholesterol to the cellular mitochondria and smooth endoplasmic 
reticulum by steroidogenic acute regulatory protein (StAR). Within the 
adrenal gland cortex, CYP11A1 (cytochrome p450, family 11, subfamily A, 
peptide 1) is the first steroidogenic enzyme in the system and converts 
cholesterol into pregnenolone, which is then further transformed to all other 
steroid hormones. Any inhibition of this enzyme could affect the whole of the 
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steroidogenic pathway (Figure 10) and would lead to a reduction in 
pregnenolone, the precursor for all steroid hormones (Nielsen et al., 2012). 
CYP17A1 (cytochrome p450, family 17, subfamily A, peptide 1) is found within 
the endoplasmic reticulum, and has both 17-alpha hydroxylase and 17, 20-
lyase activity. It is required for the production of mineralocorticoids, 
glucocorticoids, androgens and oestrogens, by converting pregnenolone to 
17-OH-pregnenolone (17-alpha hydroxylase activity), and this further to 
dehydroepiandrosterone (DHEA) (17, 20 lyase activity). 3βHSD (3-beta-
hydroxysteroid dehydrogenase) is another essential enzyme in glucocorticoid, 
mineralocorticoid, androgen and oestrogen hormone production, and 
catalyses the conversion of pregnenolone to progesterone (and their OH-
counterparts) (see Figure 10). Numerous studies have concluded that the 
weak oestrogenic chemicals, including phytoestrogens, inhibit the production 
of steroid hormones including cortisol (Ohno et al., 2002, Kaminska et al., 
2013, Mesiano et al., 1999, Ohlsson et al., 2010), aldosterone and 
testosterone (Ohlsson et al., 2010). It can therefore be assumed that EDCs 
with mild oestrogenic activity will also have the capability to inhibit steroid 
production. 
The presence of many EDCs have been confirmed within sewage sludge 
treated soil, these include DEHP, PCB congeners (as appropriate for PCB 
pollution), polybrominated diphenyl ethers (PBDEs) (including a range of 
brominated compounds) and a range of poly-aromatic hydrocarbons (PAHS) 
(Rhind et al., 2013). Many of these EDC examples have been found to have 
oestrogenic properties (Nishihara et al., 2000) as do the phytoestrogens 
found within many soy-containing food products. The phytoestrogens 
genistein and daidzein have been found to significantly suppress basal and 
ACTH-stimulated cortisol and corticosterone levels in porcine adrenocortical 
cells (Kaminska et al., 2013). Ohlsson and colleagues concluded that mixtures 
of phytochemical EDCs inhibit steroid production in an additive manner 
(Ohlsson et al., 2010). The two phytoestrogens genistein and daidzein, as well 
as additional flavenoid phytochemicals, were previously found not to interact 
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with oestrogen receptors (Kaminska et al., 2012, Ohno et al., 2002), and it 
was therefore hypothesised that instead they may interfere directly with 
steroidogenic enzymes (Kaminska et al., 2013). The mild oestrogenic activity 
of EDCs may therefore follow suit by interfereing with steroidogenic enzymes, 
inhibiting hormone synthesis. Indeed, maternal doses of PCB 118 and PCB 158 
caused significantly reduced fetal plasma cortisol levels, a significantly thinner 
fetal adrenal cortex and significant down regulation of steroid hormones in a 
sheep model (Zimmer et al., 2013). Future studies investigating the plasma 
cortisol level of the fetuses within this study would confirm if the in utero 
exposure to a mixture of EDCs within sewage sludge can alter cortisol 
production.  
 
4.2i: CYP17A1 
 
CYP17A1 is expressed strongly in the ovine fetal adrenal gland in early and 
late gestation, with a quiescent phase in the mid-gestation period. CYP17A1 
activity increases prior to the pre-term cortisol surge required for parturition 
(Han et al., 1997, Tangalakis et al., 1989).  Coulter and colleagues propose 
that the supression of CYP17A1 during the mid-gestational quiescent phase 
may be mediated by AGTR1. This receptor is found in most abundance at mid 
gestation in the ovine fetal adrenal, and it is the fall in AGTR1 expression 
towards the end of gestation which allows for ACTH mediated activation of 
CYP17A1 (Coulter et al., 2000).  
In the current study, CYP17A1 was found to be significantly affected by 
maternal exposure to sewage sludge fertiliser. Significantly less CYP17A1 
protein was detected in the late gestation treatment group compared with 
control animals, and CYP17A1 gene expression in female fetuses was also 
signficantly reduced in the late gestation group. This is in general agreement 
with the findings of Ohno and colleagues who concluded that certain mildly 
oestogenic flavenoids inhibited CYP17A1 (Ohno et al., 2002). In addition, 
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CYP17A1 inhibition was investigated by quantifying CYP17A1 activity by 
measuring DHEA production in a porcine adrenal cortex microsome assay and 
its expression by real-time PCR in H295R human adrenocortical cells. Eight out 
of 20 EDCs tested were found to inhibit CYP17A1 activity (in either the 
enzyme activity assay or at the gene expression level) including DES, 
tetrabromo-bisphenol A, methylmercury, dioctyltin chloride, SU10603, para-
methoxyamphetamine (PMA), BPA and conazole antifungal agents (Roelofs et 
al., 2013). In another study, the pesticide prochloraz was found to inhibit 
CYP17A1, shown by an increase in pregnenolone and progesterone 
(accumulated upstream of CYP17A1 in the steroidogenic pathway, see Figure 
10), and a decrease in hormones downstream (Nielsen et al., 2012). Certain 
chemicals have the capacity to increase the activity of CYP17A1; in one cell-
based study, forskolin and 8BrocAMP significantly increased the gene 
expression of CYP17A1, however, the EDC PMA significantly decreased 
CYP17A1 gene expression (Hilscherova et al., 2004).  
CYP17A1 is necessary for the production of DHEA, which is the essential 
precursor for androgens and oestrogens. In humans, 40% of androgens in 
men, and 75% (increasing to 100% post-menopause) of oestrogens in women 
are produced intracrinologically by the adrenal gland (Labrie, 1991). Primate 
adrenal glands, including fetal adrenal glands produce large volumes of DHEA 
and DHEAS, whereas other mammals, including sheep, locally produce sex 
steroids within the gonads, therefore the sheep adrenal produces less DHEA 
than the primate counterpart (Labrie, 1991).  
As DHEA production can be used to quantify CYP17A1 activity (Roelofs et al., 
2013), a decrease in CYP17A1, as observed at the protein level in the current 
study, is likely to result in a decrease in DHEA. Logically it can be concluded 
that the outcome of this will be a reduction in testosterone. In support of this, 
testosterone concentrations in the fetuses used in the current study were 
reduced in males in the late gestation exposure group (Lea et al., 2010) and 
also, in a different study, testosterone was lower in male fetuses from sewage 
sludge exposed ewes euthanised at day 110 of gestation (Paul et al., 2005). 
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Interestingly, only the mid-gestation exposure group are reported to have 
reduced testicular CYP17A1 immuno-expression (Lea et al., 2010). This raises 
the possibility that the reduction in testosterone in the late gestation 
exposure group reported by Lea and colleagues may be a reflection of the 
reduced adrenal CYP17A1 protein levels seen in the current study. In addition, 
mid-gestational testicular CYP17A1 reduction could follow the quiescent 
CYP17A1 phase normally found in the adrenal gland during mid gestation. 
However, the caveat to this is that the reduced CYP17A1 protein reflects the 
staining within the adrenal cortex rather than a direct measure of CYP17A1 
activity. Nevertheless, in a separate study, fetuses from ewes exposed 
continuously for the first 80 days of gestation also exhibit reduced numbers of 
testicular CYP17A1 immunopositive cells (Lea et al., 2010). Adrenal tissues 
from these animals have yet to be examined. Taken together, these data 
generated from the sewage sludge sheep model illustrate the sensitivity of 
CYP17A1 to EDC exposure, particularly at the protein level within both the 
fetal adrenal gland and testis.  
Although the relationship between reduced fetal testosterone and adrenal 
function requires further study, there are important implications of these 
findings for population heath. If the low fetal CYP17A1 and testosterone 
levels continue into adulthood, adult phenotypes could change: fetal onset of 
adult disease (Gluckman and Hanson, 2004). Many epidemiological studies 
have shown that lower testosterone levels in men are associated with 
cardiovascular disease, and therefore higher mortality rates, as reviewed by 
Ikeda and colleagues (Ikeda et al., 2012). Furthermore, androgen deprivation 
therapy for prostate cancer is significantly correlated with increased coronary 
heart disease, acute myocardial infarction and heart failure, when used in 
combination with LH releasing homone receptor (LHRH) agonist (Martin-
Merino et al., 2011). In addition, lower testosterone levels in men is 
associated with many chronic metabolic disease states including metabolic 
syndrome, hypertension, increase body mass index and type 2 diabetes, as 
reviewed by Moulana and colleagues, and Grossmann (Moulana et al., 2011, 
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Grossmann, 2011). The global increasing incidence of cardiovascular and 
metabolic diseases may therefore be in part atributed to EDCs, via fetal 
CYP17A1 inhibition influencing the adult phenotype.  
Fetal onset of low female adult DHEA could by hypothesised to be even  more 
detrimental than in males due to the large proportion of oestrogen derived 
from this adrenal precursor. DHEA decreases with age, and therefore a 
decrease may be linked with post-menopausal problems including 
osteoporosis, muscle atrophy, vaginal atrophy, fat accumulation, hot flushes, 
type 2 diabetes and memory loss, as reviewed by Labrie (Labrie, 1991).  
Therefore a reduction in CYP17A1, and thus DHEA, from birth could 
exacerbate post-menopausal conditions, and indeed reduce the age of 
menopause, a reported effect of many EDCs (Eskenazi et al., 2005). In further 
support of this concept, smoking is a source of the EDC PAH (Fowler et al., 
2014), and women smokers tend to experience earlier menopause (Tawfik et 
al., 2015).   However, a review of published and non-published randomised 
control trials comparing any dose and any form of DHEA administration 
concluded that there was no benefit of DHEA to reduce post-menopausal 
symptoms, other than possibly improving sexual function (Scheffers et al., 
2015).  
Lower fetal concentrations of circulating DHEA/DHEAS due to CYP17A1 
reduction could also have major consequences on pregnancy maintenance. 
The majority of pregnancy-maintaining oestrogen precursors (DHEA/DHEAS) 
are of fetal adrenal origin (Kaludjerovic and Ward, 2012), therefore it can be 
assumed that a fall in adrenal DHEA/DHEAS, either fetal or maternal, could 
result in a fall in pregnancy oestrogens. During pregnancy this can result in 
miscarriage (Albrecht et al., 2000), which was the original idea behind the use 
of the synthetic oestrogen DES to prevent miscarriage in the 1940-1970s 
(Smith, 1949). Maternal serum concentrations of conjugated BPA is 
significantly correlated with increased miscarriage rates (Lathi et al., 2014) 
and BPA has been shown to inhibit ovarian steroidogenesis in mouse follicle 
cultures including a significant decrease in DHEAS from the treated follicles 
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(Peretz et al., 2011). It could therefore be hypothesised that BPA could 
negatively affect fetal and maternal DHEA/DHEAS production, leading to a fall 
in oestrogens, resulting in the increase in miscarriages seen following BPA 
ingestion.  
Maternal DHEA and DHEAS levels are also important in conception.  In a 
double-blind, randomised, placebo-controlled trial of ageing infertile women, 
DHEA administered prior to in vitro fertilisation (IVF) therapy caused a 
significantly higher live birth rate than placebo controls (Tartagni et al., 2015), 
suggesting the importance of maternal, in addition to fetal, adrenal DHEA and 
DHEAS. The result of fetal exposure to EDCs may not be seen until adulthood, 
highlighting the concept of fetal origin of adult disease (Gluckman and 
Hanson, 2004). A fetal reduction in CYP17A1 could result in a reduction in 
DHEA and DHEAS in the adult, leading to reduced fertility. In a study of 1950 
Chinese women undergoing IVF, low basal testosterone levels were 
correlated with a significant decrease in mature oocytes, lower fertilisation, 
and lower pregnancy rate when measured on day four of the menstrual cycle 
(Guo et al., 2014). Indeed androgens, including testosterone, act 
synergistically with FSH during folliculogenesis, and are therefore important in 
the early stages of follicle maturation (Gleicher et al., 2011). Mitotaine, a drug 
used to combat the glucocorticoid excess caused by hyperadrenocortisism, is 
an isomer of dichlorodiphenyldichloroethane (DDD), and is a derivative of the 
well researched EDC DDT. Mitotaine treatment in pre-menopausal women 
was associated with a significant decrease in androgen levels including 
androstendione and testosterone, contributing to the development of ovarian 
macrocysts, menstrual abnormalities and pelvic pain (Salenave et al., 2015). 
This illustrates that EDCs may induce androgen and oestrogen deficiency via 
inhibitory effects on CYP17A1 and DHEA, and this inhibition can lead to 
female reproductive problems.  
It has been reported that exposure to EDCs can result in hypertension 
(Arrebola et al., 2015). A proposed mechanism for this observation is that a 
general reduction in physiological adrenal CYP17A1 activity, resulting from 
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adult or fetal EDC exposure as seen in the current study,  causes an androgen 
and oestrogen deficiency and a mineralocorticoid excess. As previously 
mentioned, decreased DHEA leads to a subsequent decrease in oestrogens 
and androgens. Due to the reduction in 17-hydroxylase activity of CYP17A1, 
there are also reduced 17-OH-progesterone levels, resulting in lowered 
cortisol levels. All these lowered hormone concentrations reduce the negative 
feeback on the hypothalamus and pituitary gland, resulting in an increase in 
ACTH production. ACTH activates the zona glomerulosa resulting in the 
production of pregnenolone and progesterone. Lack of CYP17A1 results in 
more precursor for CYP21 to convert to corticosterone (see Figure 10). High 
circulating concentrations of corticosterone cause supression of renin and 
expand plasma volume leading to hypertension, as shown by Marsh and 
colleague’s work on congenital CYP17A1 defficiency (Marsh and Auchus, 
2014). Due to high corticosterone, CYP11B2 expression and aldosterone are 
very low, or absent in patients with congenital CYP17A1 deficiency (Marsh 
and Auchus, 2014). 
 
4.2ii: CYP11A1 
 
In the current study, no treatment effect was found for CYP11A1 gene 
expression across the five treatment groups. In agreement with the current 
results, CYP11A1 was found not to be the mechanism by which oestrogenic 
genistein and daidzein affect human corticoadrenal H295R cells (Kaminska et 
al., 2013). Within the steroidogenic pathway, CYP11A1 converts cholesterol to 
pregnenolone, which, via a number of enzymatic conversions, results in the 
end product cortisol (see Figure 10). Phytoestrogens inhibited cortisol 
production from H295R cells, however, the addition of pregnenolone to the 
cell media did not remove this inhibition, therefore reduced pregnenolone 
due to reduced CYP11A1 activity was not the reason for the inhibition. This 
suggestes that phytoestrogens inhibited cortisol production further down the 
steroidogenesis pathway (Kaminska et al., 2013). Mesiano and collagues also 
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found that there was no interaction between phytoestrogen exposure and 
CYP11A1 gene expression (Mesiano et al., 1999). In contrast to the current 
study, in a sheep model of maternal exposure to PCB 118 (49μg/bw/day) and 
PCB 153 (98μg/bw/day) CYP11A1 gene expression was reduced (Zimmer et 
al., 2013). This could suggest that chemicals within EDC mixtures interact and 
therefore have the capability to affect adrenal glands differently when 
combined than when individually tested. This highlights the importance of the 
sewage sludge model in the current study, which exposes ewes to an 
environmentally relevant cocktail of EDCs.  
PAHs are EDCs found within cigarette smoke. In a study of human fetal 
ovaries of 11-21 weeks of gestation from social abortions,  Fowler and 
colleagues demonstrated that CYP11A1 was dysregulated in utero by 
maternal smoke exposure (Fowler et al., 2014) and concluded, as maternal 
hepatic PAH levels were increased nearly 6-fold and female fetal hepatic PAH 
concentrations were significantly increased by maternal smoking, that 
chemicals in the cigarette smoke were responsible for this effect. However, of 
relevance to the current study, liver concentrations of PAHs in the ovine 
sewage sludge model were not significantly affected by sewage sludge 
exposure compared with controls in either maternal or fetal liver samples 
(Rhind et al., 2010b). Therefore the lack of PAH accumulation within the 
fetuses observed here could be one reason for a lack of any observed effect 
of maternal exposure to contaminated pasture and fetal CYP11A1 gene 
expression. This underlies the strengths of the real-life ovine model, as the 
effects seen reflect the EDC composition of the model.  
 
4.2iii: 3βHSD 
 
Using porcine adrenocortical cells,  Kaminska and colleagues concluded that 
phytoestrogens inhibit steroidogenesis at the level of 3βHSD. 3βHSD converts 
pregnenolone to progesterone, which is then further converted to cortisol 
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within the steroidogenic pathway. Cortisol production was inhibited by the 
addition of the EDCs, however, on the addition of progesterone, this 
inhibition was reversed, concluding that the inhibition was at the level of 
3βHSD (Kaminska et al., 2013) (see Figure 10). In contrast, the current study 
showed no treatment effect on 3βHSD gene expression, although there was a 
gender difference. Male fetuses expressed significantly more 3βHSD than 
female fetuses in the mid-gestation treatment group. Interestingly the 
Kaminska study described above used adrenocortical cells from only female 
adult pigs, thus effects may be gender specific.  
Isoflavones have also been found to inhibit the activity of 3βHSD in bovine 
adrenocortical cells (Wong and Keung, 1999) and human H295R 
adrenocortical cells (Ohno et al., 2004). However, it is important to note that 
these two studies, as well as that of Kaminska, were all in vitro cell-based 
studies which do not take into account whole animal physiology. Nielson and 
colleagues investigated the inhibiting effects of the three EDCs prochloraz (a 
pesticide), ketoconazole (an anti-fungal) and genistein (a phytoestrogen) on 
human H295 adrenocortical cells, concluding that only genistein out of the 
three compounds tested inhibited 3βHSD. This was highlighted by an increase 
in pregnenolone and dehydroepiandrosterone (upstream of 3βHSD) and a 
decrease in androstendione and estrone (downstream) (Nielsen et al., 2012). 
This highlights the variablility of EDC activity and the importance of 
investigating an everyday cocktail found within the current study, as well as 
an in in vitro versus in vivo models.  
 
4.3: Steroidogenic Receptors  
 
4.3i: Angiotensin Receptors  
 
In addition to chronic low levels of glucocorticoids and androgens caused by 
EDC interactions within the adrenal, EDCs have also been found to reduce 
 
 
Page | 112 
 
mineralocorticoid levels (Martinez-Arguelles et al., 2014). This could be at 
receptor level, including AGTR1, or again within the steroidogenic pathway.  
Data generated in this study showing reduced adrenal AGTR1 protein and the 
effects on adrenal CYP17A1 may therefore reflect a sensitivity of the zona 
glomerulosa to EDCs. Additionally, cortical staining for AGTR1 was 
significantly reduced in the late exposure group with the females more 
affected than the males.  
AGTR1 is activated by the vasoconstrictor angiotensin-II which, initiates 
aldosterone production within the zona glomerulosa of the adrenal cortex. In 
sheep, by mid-gestation half the aldosterone in fetal blood is of fetal adrenal 
origin, however, increased plasma potassium or angiotensin-II do not increase 
aldosterone secretion until near term (Coulter et al., 2000). Therefore the 
reduction of AGTR1 protein in the late gestation exposure group in the 
current study could lead to reduced aldosterone in late pregnancy. There is a 
high fluid volume demand during pregnancy, and this increase is partially 
induced by aldosterone (Chapman et al., 1998). Indeed, failure of this volume 
expansion can result in the development of preeclampsia and growth 
retardation (Hays et al., 1985). As aldosterone concentrations correlate with 
plasma volume expansion (Salas et al., 2006) and placental size (Gennari-
Moser et al., 2011) during pregnancy, it has been hypothesised that low 
aldosterone, leading to lower blood volume and resulting vasoconstriction, is 
a contributing factor to preeclampsia and reduced placental perfusion 
(Shojaati et al., 2004) in primates with initial placental pathology. In 
aldosterone synthase knock out mice, dams were found to be hypotensive 
before pregnancy, and even more so during pregnancy, leading to a reduced 
litter size and reduced placental perfusion (Todkar et al., 2012). In addition, 
aldosterone has been suggested to be part of an adaptive pathway in 
conditioning pregnancies to the changing environment by modulating 
trophoblast growth and placental size (Gennari-Moser et al., 2011).  Since 
80% of mid-gestation fetal blood aldosterone is of fetal adrenal origin, 
environmental factors that affect aldosterone levels may indirectly affect 
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blood pressure, placental development and function and thus theoretically 
negatively impact on pregnancy maintenance via a number of different 
mechanisms including the reduced AGTR1 found in the current study. The 
reason for the apparent increased sensitivity of the female adrenal to EDCs is 
uncertain, however, there are gender differences within the normal 
physiology of the HPA, whereby the female HPA is more active than in the 
male.  
In terms of the localisation of adrenal AGTR1, the current study showed 
staining of both the zona glomerulosa and zona fasciculata of the developing 
adrenal cortex. In a separate published study, Coulter and colleagues also 
reported intense zona glomerulosa staining but in contrast to the current 
study, they found less intense and more limited staining in the zona 
fasciculata (Coulter et al., 2000). Both studies found intense staining at the 
cortico-medullary boundary and around the central medullary vein, however, 
in the current study localised, sporadic medullary staining was also present. In 
agreement with data presented in this thesis, Wintour and colleagues found 
immunostaining for AGTR1 in the developing zona glomerulosa, within the 
steroidogenic cells of the developing zona fasciculata, and scattered 
throughout the medulla at 60, 100 and 130 days of gestation (Wintour et al., 
1999). Subtle differences in localisation between studies probably reflect 
different antibody sources and specificities (polyclonal from Abcam (current 
study), polyclonal from Santa Cruz Biotechnology (Coulter) and three 
antibodies in Wintour).  
In utero exposure to phthalates, in particularly DEHP, has been shown to have 
anti-androgenic effects. A DEHP induced reduction in testicular testosterone 
production in rat adult male offspring which were exposed in utero 
throughout the second half of gestation, was found to be due to a decrease in 
mineralocorticoid receptors (MRs) within Leydig cells (Martinez-Arguelles et 
al., 2014). A novel hypothesis for further testosterone reduction, in addition 
to reductions in CYP17A1 and testicular MRs, is a reduction of adrenal 
aldosterone. Indeed, a reduction in aldosterone was found in 60-day-old male 
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offspring after in utero DEHP exposure (Martinez-Arguelles et al., 2014) and 
aldosterone is known to stimulate testosterone and LH production in the 
testis as an exogenous ligand of MRs (Ge et al., 2005). This suggests that the 
adrenal-testis-testosterone-producing axis is sensitive to DEHP (Martinez-
Arguelles et al., 2014), again highlighting the importance of the adrenal in 
producing gonadal steroids (intracrinology). Martinez-Arguelles and 
colleague’s rat study of in utero exposure to DEHP also concluded that DEHP 
affected cholesterol bioavailability and steroidogenesis in the adrenal gland of 
offspring. Although aldosterone levels were decreased, neither angiotensin-II, 
potassium, corticosterone nor ACTH levels were affected, indicative of a DEHP 
affect on the zona glomerulosa.  In addition, angiotensinogen synthesised in 
the liver, and renin synthesized in the kidney, were normal, again suggesting 
an adrenal aetiology of aldosterone reduction (Martinez-Arguelles et al., 
2014).  
Further studies by Martinez-Arguelles and colleagues showed that, after in 
utero exposure to DEHP, adult rat aldosterone concentrations remained 
similar to those from pubescent rats (approximately half the normal adult 
concentration), suggesting that DEHP targets maturation of the zona 
glomerulosa (Martinez-Arguelles et al., 2014). In the same rat study, 
expression of angiotensin-II receptors, including AGTR1, were also reduced by 
DEHP at very high concentrations (more than 300mg/kg/day), further 
highlighting the importance of the current study, in which AGTR1 was 
decreased by an environmentally relevant concentration and mixture of EDCs. 
Indeed, these authors hypothesised that the reduction in AGTR1 is likely 
linked to the reduced aldosterone observed in the same animals (Martinez-
Arguelles and Papadopoulos, 2014, Martinez-Arguelles et al., 2014). 
In the DEHP rat study described above, Martinez-Arguelles and colleagues 
also found a gender specific action of DEHP on male offspring. In the current 
study, however, a treatment by gender interaction was observed with the 
females being more affected than the males in the mid and late exposure 
treatment groups. Since their study only focused on DEHP, the current 
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investigation is more representative of real life exposure to a mixture of 
environmental contaminants. In addition, within this mixture there will 
inevitably be both synergistic and additive interactions also representative of 
real life exposure. 
The mechanism by which reduced AGTR1 may cause reduced testosterone 
levels has been discussed. However, since aldosterone is responsible for 
maintaining blood pressure, EDC induced changes in blood pressure could 
also work via this mechanism. In the Martinez-Arguelles rat model, DEHP 
exposure administered by maternal gavage from day 14 of gestation until 
parturition decreased the night time systolic blood pressure of male offspring 
when they reached 200-days of age (“old”). These male offspring maintained 
on a low sodium diet (0.01% NaCl) demonstrated decreased diastolic blood 
pressure and there was also a significant decrease in their night activity. This 
suggests DEHP alters basal aldosterone mechanisms (Martinez-Arguelles et 
al., 2014). This also suggests that EDCs within sewage sludge, which reduce 
AGTR1, have the potential to reduce aldosterone concentrations and to 
reduce blood pressure. They also have the potential to cause behavioural 
changes via reduced testosterone (Martinez-Arguelles et al., 2014). In an 
ovine model of in utero exposure to sewage sludge throughout the entirety of 
maternal life and gestation has also been shown to affect behaviour in 5-
month-old offspring (Erhard and Rhind, 2004). Since the ovine model 
described in this thesis investigated actual environmental concentrations and 
cocktails of ubiquitous EDCs at different windows of gestation, it follows that 
hormone concentrations, blood pressure and behaviour may be useful indices 
for further studies using this established ovine paradigm.  
 
4.3ii: Oestrogen Receptors  
 
In the current study, fetal oestrogen receptor 1 (ER1) gene expression was 
significantly affected in utero following maternal exposure to EDCs; with ER1 
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being expressed significantly less in the mid and late gestation treatment 
groups compared to controls. Many EDCs are mildly oestrogenic (Nishihara et 
al., 2000) and therefore have been found to act upon oestrogen receptors 
(ERs) (Hamlin and Guillette, 2011). There is little known about ERs within the 
ovine adrenal glands; however, ERs are found within all three adrenocortical 
zones, and within the adrenal medulla in the adult sheep (van Lier et al., 
2003a). van Lier and colleagues showed that there was no difference in ER1 
distribution or levels in male and female sheep or gonadectomised sheep (van 
Lier et al., 2003a). Similarly, in the current study, no gender differences were 
found in ER1 gene expression. The presence of ERs within the adrenal glands 
indicate the importance of oestrogen activation of the adrenal gland. That 
oestrogen stimulates the adrenal gland was shown by Lo and colleagues, who 
demonstrated that administration of oestrogen benzoate significantly 
increased plasma corticosterone levels from the rat zona fasciculata and zona 
reticualis in a dose dependent manner (Lo et al., 2000). Therefore any 
disruption of ERs within the adrenal gland could affect the ability of the HPA 
axis to fully respond to stressors. The decrease in ER1 gene expression 
demonstrated in the current study could therefore result in reduced 
activation of the HPA axis by endogenous oestrogens at the adrenal level.  
Oestrogen modulators also have the capacity to alter catecholamine secretion 
from the adrenal medulla. In bovine adrenal medullary cells, low 
concentrations of raloxifene and tamoxifen modulate ERs (via their allosteric 
site), and at high concentrations inhibit catecholamine synthesis and 
secretion by inhibiting sodium and calcium influx via acetylcholine (Inagaki et 
al., 2014). The isoflavenone daidzein stimulates catecholamine synthesis via 
ERs in bovine adrenal medullary cells; however, high concentrations inhibit 
catecholamine synthesis and secretion (Liu et al., 2007). In a mouse model, in 
utero exposure to arsenic and post-natal exposure to DES did not separately 
affect ER1 gene expression; however, in utero exposure to arsenic enhanced 
ER1 modulation by post-natal DES exposure; this combined exposure 
increased ER1 gene expression (Liu et al., 2009). The current study is the first 
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to investigate and conclude that in utero exposure to EDCs alter the fetal 
expression of ER1 within the adrenal gland when exposed from 30 to 100, or 
60 to 140 days of gestation to a mixture of chemicals. 
 
4.3iii: Melanocortin Receptors 
 
Alterations in the melanocortin receptor MC2R can result in adrenopathology 
including clinical signs associated with hyperadrenocortisism (Cushing’s 
disease) or hypoadrenocorticism (Addison’s disease) (Yang et al., 2015). The 
current yet limited literature on the interaction of EDCs and MC2R suggest 
adrenal dysregulation caused by EDCs occurs at a different receptor level than 
MC2R or within the steroidogenic pathways. The current real life study also 
shows a good indication that an everyday cocktail of EDCs does not affect 
fetal MC2R development; no differences in gene expression of MC2R was 
found across the gestation treatment groups within this study. In a rodent 
study, chronic in utero exposure to the EDC tetrabromobiphenol A was found 
to significantly modulate the transcription of MC4R within fetal hypothalamic 
PVN samples, however, organotin tributylin (TBT) exposure caused no such 
effect (Decherf et al., 2010). This suggests different MCRs may be sensitive to 
the effects of specific EDCs; however, the study by Decherf and colleagues did 
not include MC2R, and only investigated two EDC out of possibly thousands. 
Similarly to the current study, the EDC cadmium was shown not to alter 
mRNA levels of basal MC2R levels in a cell-based study of adrenal cells in 
rainbow trout kidneys (Sandhu and Vijayan, 2011), Teleosts do not have 
separate adrenal glands instead adrenal tissue is located within the cranial 
pole of the kidney.  
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4.4: Future work  
 
In order to understand more fully the effects of exposure of EDCs on the 
developing fetus, and the long term implications of such exposure, there are a 
number of lines of enquiry that it would be profitable to pursue. It would be 
interesting to investigate the rate limiting step of steroiodogenesis in the 
sewage sludge model by investigating gene expression of StAR in addition to 
the other steroidogenic enzymes within the hormone pathway which were 
not included in the current study including CYP12A1 (aldosterone synthase). 
Serum hormone concentrations of cortisol, aldosterone, androgens and 
oestrogens from dams and fetuses would also be of interest. In addition to 
fetal studies, investigating possible disease progression in offspring including 
behaviour, mating behaviour, stress responses, and fertility, as well as the 
molecular makers included in this study would be of great importance in F1, 
F2 and F3 generations. Measuring systolic blood pressure of offspring across 
the different treatment groups, and changes during growth especially during 
pregnancy would be beneficial. In addition, it would be advantageous to 
complete a study on the impacts of direct depots of sex hormones, 
investigating a purely androgenic or oestrogenic insult on ovine fetal 
development. Future work on environmentally relevant mixtures of EDCs 
could then be investigated and referred to the “oestrogen” or “androgen” 
pattern to decipher the hormonal activity of the EDC cocktail as a whole, to 
investigate linkages or common effects. Larger screening studies including 
micro-arrays, next generation sequencing and proteomics could be used to 
find novel EDC targets.  
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4.5: Limitations  
 
4.5i: Immunostaining 
 
The sections processed for immunohistochemistry analyses were harvested 
and immediately fixed in Bouin’s solution in 2008 and stored in 70% ethanol 
at 4oC; however, some tissues had dried out during this time period, and 
these could not be included in analyses. It is unknown if this time period may 
have affected the expression of protein in the tissue samples that were 
investigated. However, due to the specificity of the staining, and the 
negativity of the IgG controls, it is likely that these results are valid and not 
compromised by non-specific binding. Presumably as a consequence of the 
age of the tissue, a number of sections did not remain intact during the 
immunohistochemical procedure; the edges of the tissue curled over, or areas 
of the adrenal tissue dislodged completely from the slide. In these situations, 
the eight measurements of cortical staining for each of the antibodies was 
completed at even distances across the available tissue to get as full a 
representation as possible of the entire cortex. Percentage area stained was 
completed for the section of tissue that remained on the slide. All results 
therefore have to be considered with this in mind.  
 
4.5ii: Real Time PCR 
 
Ideally primers could have been designed to span intron boundaries to 
obviate any possibility of amplifying contaminating genomic DNA. However, 
as an alternative approach to minimise the chance of genomic amplification, a 
DNase digestion step was included during the RNA extraction step. In 
addition, reverse transcriptase negative controls were run, and results from 
these controls clearly showed the negligible contribution of contaminating 
genomic DNA to the amplification. Sequencing of the PCR products was not 
 
 
Page | 120 
 
possible for any gene other than YWHAZ due to the small amplicon size. 
However, further optimisation by electrophoresis of the qRT-PCR products 
confirmed that the size of the amplicons was as expected for each gene. 
Unfortunately, due to limited availability of one of the ER1 primers  that had 
been designed prior to the start of this project, gel electrophoresis and RT-
negative controls were not completed for this gene of interest.  
 
4.6: Broader Implications 
 
4.6i: Wildlife 
 
Adrenal dysfunction caused by EDCs has been found in wildlife, including 
marine mammals, arctic mammals and birds. High body concentrations of 
PCBs and DDT compounds within Baltic seal populations caused a massive 
population decline in the 1970s. The seals exhibited characteristics of 
Cushing’s disease and adrenal cortex hyperplasia (Bergman, 1999). Dolphins 
from the oil-spill area of Baratana Bay have significantly lower adrenal 
hormone blood levels than dolphins in clean waters. This was found to be the 
case for cortisol eve after taking into account circadian variations of this 
hormone, and aldosterone, which were both significantly lower than blood 
concentrations in the control animals (Schwacke et al., 2014). High blood 
plasma concentrations of brominated flame-retardants and organochlorides 
in glaucous gulls (Larus hyperboreus) has been associated with high 
corticosterone concentration in both genders, and an altered stress response 
in males (Verboven et al., 2010). EDCs have the potential to alter and 
decrease the natural stress response, by dampening down glucocorticoid 
production, which therefore has the ability to impair an animal’s survival 
fitness (Harvey, 2014).  
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4.6ii: Humans 
 
It is hypothesised that in domestic mammals, there is a low-grade cortisol 
insufficiency, and this is likely to have an environmental aetiology (Plechner, 
2004), and, in addition, such a low-grade cortisol deficiency has been 
suggested in humans (Jefferies, 1994). As previously described, most 
investigations have been completed on the reproductive aspects of EDC 
perturbations, focusing on the HPG axis, therefore this work on the fetal 
adrenal is novel and of great importance. Indeed, the adrenal gland is the 
most commonly targeted endocrine organ in toxic insults, more specifically, 
the adrenal cortex, and more specifically still, the zona fasciculata and zona 
reticularis are the most commonly affected regions of the adrenal gland by 
toxins (Rosol et al., 2001). Inhibition of normal adrenal cortex physiology and 
function has been noted to cause detrimental and fatal consequences in the 
human. For example, to causes of fatal adrenal dysfunction include the 
anaesthetic agent etomidate, and the anti-convulsant medication 
aminogluthiamide, both of which caused death via Addisonian crises. These 
are examples where single doses, at reasonably low concentrations, can still 
have fatal consequences via adrenal inhibition (Harvey, 2014, Harvey et al., 
2007).  
Pharmaceuticals can fatally inhibit the adrenal gland, and low level adrenal 
deficiency is common in domestic mammals (Plechner, 2004). The current 
study shows EDCs perturb fetal adrenal gland development, and therefore it 
is hypothesised that EDCs may be linked to low-level adrenal pathology. 
Altered adrenal function, however mild, can have very wide pathological 
responses in mammalian physiology, including effects on the stress response, 
the thyroid system, the pancreas and the gonads (Harvey, 2014). The HPA axis 
is activated at times of stress (physical, infection, injury, toxic insult), when 
the body is most vulnerable to toxic insults, and therefore any suppression of 
the full HPA axis response can be detrimental (Harvey, 2014).  
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In humans, there are a number of conditions that are caused by abnormalities 
of the adrenal cortex and adrenal steroidogenesis, and as EDCs are already 
known to interfere with steroid synthesis, it is plausible that such conditions 
could at least in part be chemically induced, leading to adrenal insufficiency 
(Harvey, 2014). Some examples of altered or mutated adrenal 
steroidogeneisis causing human disease are: adrenogenital syndrome (Hakki 
and Bernhardt, 2006), an increase in aldosterone production leading to 
hypertension and cardiovascular disease (Arrebola et al., 2015), an increase in 
certain CYP17A1 genotypes known to correlate with increased prostate 
cancer (Madigan et al., 2003), and defects in aldosterone synthesis leading to 
reduced aldosterone and salt-wasting syndrome in babies, which can be fatal 
unless treated (White, 2004).  
 
4.7: Conclusion 
 
This study, for the first time has demonstrated that in utero exposure to an 
environmentally relevant concentration and mixture of EDCs found within 
processed human sewage sludge dysregulates the developing ovine fetal 
adrenal gland. More specifically, in utero exposure to EDCs within sewage 
sludge during mid and late gestation reduces ER1 gene expression and, 
particularly in female offspring, reduces levels of AGTR1 and CYP17A1 
protein. It is hypothesised that this fetal dysregulation, leading to altered fetal 
and possible adult steroidogenesis, could contribute to increasing human 
chronic dieases including infertility, hypertension and metabolic diseases, and 
to the declining biodiversity in wildlife. More importantly, this study highlights 
the need for further EDC research into delining fertility to be broadened to 
include the perturbed reproductive activities of the HPA axis.  
In terms of the agricultural practice of using sewage sludge based fertiliser, 
data presented in this study add to the weight of evidence that this practice 
may require regulation at national and international levels. Indeed, over 10 
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million tonnes of dry matter sewage sludge fertiliser containing a mixture of 
EDCs are used annually in the EU (Laturnus et al., 2007).  Therefore these new 
data could be used to argue for a reduction in the treatment of agricultural 
land with such material for use in animal management, and thus reduce 
exposure to these harmful chemicals. Indeed, Switzerland has already banned 
sewage sludge fertiliser usage for animal management practices (Wager, 
2007). Adding to the previous work completed on the ovine sewage sludge 
model, these results further strengthen the augment that the EU should 
follow in Switzerland’s footsteps to ban or at least reduce the use of 
processed human sewage sludge as a fertiliser in animal management 
systems.  
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